10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended August 31, 2019

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ..... to …..

Commission file number: 001-14669

HELEN OF TROY LIMITED

(Exact name of registrant as specified in its charter)

Bermuda     74-2692550

(State or other jurisdiction of incorporation or organization)    (I.R.S. Employer Identification No.)                

Clarendon House, 2 Church Street, Hamilton, Bermuda                                    

(Address of principal executive offices)            

1 Helen of Troy Plaza, El Paso, Texas             79912

(Registrant’s United States Mailing Address)            (Zip Code)

(915) 225-8000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Shares, $0.10 Par Value Per Share	HELE	The NASDAQ Stock Market, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).       Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒                            Accelerated filer ☐

Non-accelerated filer ☐ Smaller reporting company ☐

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of October 4, 2019 there were 25,163,993 shares of common stock of the registrant, $0.10 par value per share, outstanding.

HELEN OF TROY LIMITED AND SUBSIDIARIES

FORM 10‐Q

TABLE OF CONTENTS

		PAGE
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements	2
	Note 1   - Basis of Presentation and Related Information	7
	Note 2   - New Accounting Pronouncements	8
	Note 3   - Revenue Recognition	8
	Note 4   - Leases	9
	Note 5   - Discontinued Operations	10
	Note 6   - Supplemental Balance Sheet Information	11
	Note 7   - Goodwill and Intangible Assets	11
	Note 8   - Share-Based Compensation Plans	13
	Note 9   - Repurchase of Helen of Troy Common Stock	14
	Note 10 - Restructuring Plan	15
	Note 11 - Commitments and Contingencies	15
	Note 12 - Long-Term Debt	16
	Note 13 - Fair Value	17
	Note 14 - Financial Instruments and Risk Management	18
	Note 15 - Accumulated Other Comprehensive Income (Loss)	21
	Note 16 - Segment Information	21
	Note 17 - Income Taxes	22
	Note 18 - Earnings Per Share	23
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	48
Item 4.	Controls and Procedures	49
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	49
Item 1A.	Risk Factors	49
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	50
Item 6.	Exhibits	51
SIGNATURES		52

1

PART I.   FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except shares and par value)	August 31, 2019			February 28, 2019
Assets
Assets, current:
Cash and cash equivalents	$	17,031		$	11,871
Receivables - principally trade, less allowances of $1,350 and $2,032	310,377			280,280
Inventory	370,915			302,339
Prepaid expenses and other current assets	13,048			10,369
Total assets, current	711,371			604,859
Property and equipment, net of accumulated depreciation of $130,059 and $123,744	131,164			130,338
Goodwill	602,320			602,320
Other intangible assets, net of accumulated amortization of $189,771 and $181,463	283,186			291,526
Operating lease assets	34,429			—
Deferred tax assets, net	12,398			7,991
Other assets, net of accumulated amortization of $2,161 and $2,115	1,085			12,501
Total assets	$	1,775,953		$	1,649,535
Liabilities and Stockholders' Equity
Liabilities, current:
Accounts payable, principally trade	$	166,684		$	143,560
Accrued expenses and other current liabilities	149,271			165,160
Income taxes payable	18			1,427
Long-term debt, current maturities	1,884			1,884
Total liabilities, current	317,857			312,031
Long-term debt, excluding current maturities	299,309			318,900
Lease liabilities, non-current	42,470			—
Deferred tax liabilities, net	8,323			5,748
Other liabilities, non-current	20,619			16,219
Total liabilities	688,578			652,898
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	—			—
Common stock, $0.10 par. Authorized 50,000,000 shares; 25,130,204 and 24,946,046 shares issued and outstanding	2,513			2,495
Additional paid in capital	256,995			246,585
Accumulated other comprehensive income (loss)	(4,755		)	1,191
Retained earnings	832,622			746,366
Total stockholders' equity	1,087,375			996,637
Total liabilities and stockholders' equity	$	1,775,953		$	1,649,535

See accompanying notes to condensed consolidated financial statements.

2

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Income (Unaudited) 

	Three Months Ended August 31,						Six Months Ended August 31,
(in thousands, except per share data)	2019			2018			2019			2018
Sales revenue, net	$	413,995		$	393,548		$	790,330		$	748,227
Cost of goods sold	235,844			238,375			458,452			446,496
Gross profit	178,151			155,173			331,878			301,731
Selling, general and administrative expense ("SG&A")	123,201			103,654			229,102			205,160
Restructuring charges	430			859			1,049			2,584
Operating income	54,520			50,660			101,727			93,987
Non-operating income, net	89			85			221			160
Interest expense	(3,216		)	(2,755		)	(6,524		)	(5,442		)
Income before income tax	51,393			47,990			95,424			88,705
Income tax expense	5,298			3,973			8,635			6,515
Income from continuing operations	46,095			44,017			86,789			82,190
Loss from discontinued operations, net of tax	—			—			—			(381		)
Net income	$	46,095		$	44,017		$	86,789		$	81,809
Earnings (loss) per share - basic:
Continuing operations	$	1.84		$	1.67		$	3.46		$	3.11
Discontinued operations	—			—			—			(0.01		)
Total earnings per share - basic	$	1.84		$	1.67		$	3.46		$	3.09
Earnings (loss) per share - diluted:
Continuing operations	$	1.83		$	1.66		$	3.44		$	3.09
Discontinued operations	—			—			—			(0.01		)
Total earnings per share - diluted	$	1.83		$	1.66		$	3.44		$	3.07
Weighted average shares of common stock used in computing earnings per share:
Basic	25,116			26,359			25,068			26,467
Diluted	25,245			26,557			25,245			26,612

See accompanying notes to condensed consolidated financial statements.

3

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Unaudited) 

	Three Months Ended August 31,					Six Months Ended August 31,
(in thousands)	2019			2018		2019			2018
Net income	$	46,095		$	44,017	$	86,789		$	81,809
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps	(3,168		)	101		(7,161		)	205
Cash flow hedge activity - foreign currency contracts	424			478		1,215			3,811
Total other comprehensive income (loss), net of tax	(2,744		)	579		(5,946		)	4,016
Comprehensive income	$	43,351		$	44,596	$	80,843		$	85,825

See accompanying notes to condensed consolidated financial statements.

4

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

	Common Stock					Additional Paid in Capital			Accumulated Other Comprehensive Income (Loss)			Retained Earnings			Total Shareholders' Equity
(in thousands, including shares)	Shares		Par Value
Balances at May 31, 2018	26,317		$	2,629		$	233,783		$	4,068		$	783,217		$	1,023,697
Income from continuing operations	—		—			—			—			44,017			44,017
Loss from discontinued operations	—		—			—			—			—			—
Other comprehensive income (loss), net of tax	—		—			—			579			—			579
Exercise of stock options	67		7			3,452			—			—			3,459
Net issuance and settlement of restricted stock	3		—			—			—			—			—
Issuance of common stock related to stock purchase plan	—		—			—			—			—			—
Common stock repurchased and retired	(7	)	—			(292		)	—			(400		)	(692		)
Share-based compensation	—		—			4,689			—			—			4,689
Cumulative effect of accounting change	—		(1		)	1			—			(9		)	(9		)
Balances at August 31, 2018	26,380		$	2,635		$	241,633		$	4,647		$	826,825		$	1,075,740
Balances at February 28, 2018	26,576		$	2,658		$	230,676		$	631		$	780,494		$	1,014,459
Income from continuing operations	—		—			—			—			82,190			82,190
Loss from discontinued operations	—		—			—			—			(381		)	(381		)
Other comprehensive income (loss), net of tax	—		—			—			4,016			—			4,016
Exercise of stock options	111		11			5,504			—			—			5,515
Net issuance and settlement of restricted stock	140		14			(14		)	—			—			—
Issuance of common stock related to stock purchase plan	17		2			1,333			—			—			1,335
Common stock repurchased and retired	(464	)	(46		)	(6,877		)	—			(35,317		)	(42,240		)
Share-based compensation	—		—			11,013			—			—			11,013
Cumulative effect of accounting change	—		(4		)	(2		)	—			(161		)	(167		)
Balances at August 31, 2018	26,380		$	2,635		$	241,633		$	4,647		$	826,825		$	1,075,740
Balances at May 31, 2019	25,101		$	2,510		$	249,079		$	(2,011	)	$	786,601		$	1,036,179
Income from continuing operations	—		—			—			—			46,095			46,095
Other comprehensive income (loss), net of tax	—		—			—			(2,744		)	—			(2,744		)
Exercise of stock options	27		2			1,805			—			—			1,807
Net issuance and settlement of restricted stock	5		1			(1		)	—			—			—
Issuance of common stock related to stock purchase plan	—		—			—			—			—			—
Common stock repurchased and retired	(3	)	—			(269		)	—			(74		)	(343		)
Share-based compensation	—		—			6,381			—			—			6,381
Balances at August 31, 2019	25,130		$	2,513		$	256,995		$	(4,755	)	$	832,622		$	1,087,375
Balances at February 28, 2019	24,946		$	2,495		$	246,585		$	1,191		$	746,366		$	996,637
Income from continuing operations	—		—			—			—			86,789			86,789
Other comprehensive income (loss), net of tax	—		—			—			(5,946		)	—			(5,946		)
Exercise of stock options	62		6			3,627			—			—			3,633
Net issuance and settlement of restricted stock	178		18			(18		)	—			—			—
Issuance of common stock related to stock purchase plan	15		1			1,407			—			—			1,408
Common stock repurchased and retired	(71	)	(7		)	(8,591		)	—			(533		)	(9,131		)
Share-based compensation	—		—			13,985			—			—			13,985
Balances at August 31, 2019	25,130		$	2,513		$	256,995		$	(4,755	)	$	832,622		$	1,087,375

See accompanying notes to condensed consolidated financial statements.

5

HELEN OF TROY LIMITED AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

	Six Months Ended August 31,
(in thousands)	2019			2018
Cash provided by operating activities:
Net income	$	86,789		$	81,809
Less: Loss from discontinued operations	—			(381		)
Income from continuing operations	86,789			82,190
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation and amortization	16,116			15,295
Amortization of financing costs	509			507
Non-cash operating lease asset amortization	1,022			—
Provision for doubtful receivables	313			597
Non-cash share-based compensation	13,985			11,013
(Gain) loss on the sale or disposal of property and equipment	(13		)	49
Deferred income taxes and tax credits	4			5,650
Changes in operating capital, net of effects of acquisition of businesses:
Receivables	(30,410		)	(38,647		)
Inventories	(68,576		)	(33,317		)
Prepaid expenses and other current assets	(2,333		)	(5,169		)
Other assets and liabilities, net	22,284			(906		)
Accounts payable	23,124			21,867
Accrued expenses and other current liabilities	(20,418		)	(21,529		)
Accrued income taxes	(4,185		)	(289		)
Net cash provided by operating activities - continuing operations	38,211			37,311
Net cash used by operating activities - discontinued operations	—			(381		)
Net cash provided by operating activities	38,211			36,930
Cash used by investing activities:
Capital and intangible asset expenditures	(8,861		)	(13,061		)
Proceeds from the sale of property and equipment	—			—
Net cash used by investing activities - continuing operations	(8,861		)	(13,061		)
Net cash used by investing activities - discontinued operations	—			—
Net cash used by investing activities	(8,861		)	(13,061		)
Cash used by financing activities:
Proceeds from line of credit	283,400			292,300
Repayment of line of credit	(301,600		)	(279,700		)
Repayment of long-term debt	(1,900		)	(1,900		)
Proceeds from share issuances under share-based compensation plans	5,041			6,848
Payments for repurchases of common stock	(9,131		)	(42,240		)
Net cash used by financing activities - continuing operations	(24,190		)	(24,692		)
Net cash used by financing activities - discontinued operations	—			—
Net cash used by financing activities	(24,190		)	(24,692		)
Net increase (decrease) in cash and cash equivalents	5,160			(823		)
Cash and cash equivalents, beginning balance	11,871			20,738
Cash and cash equivalents, ending balance	17,031			19,915
Less: Cash and cash equivalents of discontinued operations, ending balance	—			—
Cash and cash equivalents of continuing operations, ending balance	$	17,031		$	19,915
Supplemental non-cash items not included above resulting from the adoption of ASC 842
Initial recognition of operating lease asset	$	(37,082	)	$	—
Initial recognition of lease liabilities	47,223			—
Accrued expenses and other current liabilities	(2,873		)	—
Other assets and liabilities, net	(7,311		)	—
Prepaid expenses and other current assets	43			—

See accompanying notes to condensed consolidated financial statements.

6

HELEN OF TROY LIMITED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

August 31, 2019

Note 1 - Basis of Presentation and Related Information

The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2019 and February 28, 2019, and the results of our consolidated operations for the interim periods presented.  We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2019, and our other reports on file with the Securities and Exchange Commission (“SEC”).

When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. We refer to our common shares, par value $0.10 per share, as “common stock.” References to the "FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to United States (“U.S.”) generally accepted accounting principles.  References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB.  References to "ASC" refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994.  We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products.  We have three segments: Housewares, Health & Home, and Beauty.  Our Housewares segment provides a broad range of innovative consumer products for the home.  Product offerings include food preparation tools and storage containers; cleaning, bath and garden tools and accessories; infant and toddler care products; and insulated beverage, food containers and coolers.  The Health & Home segment focuses on health care devices such as thermometers, humidifiers, blood pressure monitors, and heating pads; water filtration systems; and small home appliances such as portable heaters, fans, air purifiers, and insect control devices.  Our Beauty segment products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid-, solid- and powder-based personal care and grooming products.

On December 20, 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries to Direct Digital, LLC.  The results of the Nutritional Supplements operations have been reported as discontinued operations for all periods presented in the consolidated financial statements.  For more information, see Note 5 to these condensed consolidated financial statements.  All other notes present results from continuing operations.

Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30^th.  We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States.

Our condensed consolidated financial statements are prepared in U.S. Dollars.  All intercompany accounts and transactions are eliminated in consolidation.

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

7

We have reclassified, combined or separately disclosed certain amounts in the prior years’ condensed consolidated financial statements and accompanying footnotes to conform with the current period’s presentation.

Note 2 – New Accounting Pronouncements

Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K for the fiscal year ended February 28, 2019.  

Adopted in Fiscal 2020

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The new guidance requires the recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and corresponding right-of-use assets on a balance sheet for most leases, along with requirements for enhanced disclosures to give financial statement users the ability to assess the amount, timing and uncertainty of cash flows arising from leasing arrangements. In July 2018, the FASB issued guidance which permits application of the new guidance at the beginning of the year of adoption, recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, in addition to the method of applying the new guidance retrospectively to each prior reporting period presented. We adopted the standard in the first quarter of fiscal 2020 using the transition method introduced by ASU 2018-11, which does not require revisions to comparative periods. We elected to implement the transition package of practical expedients permitted within the new standard, which included (i) not reassessing whether expired or existing contracts contain leases, (ii) not reassessing lease classification, and (iii) not revaluing initial direct costs for existing leases. Adoption of the new standard resulted in the recording of initial lease assets and lease liabilities of approximately $37.1 million and $47.2 million, respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to deferred rent and unamortized lease incentives recorded in accordance with the previous lease guidance. The new standard did not materially impact our condensed consolidated statements of income or cash flows (see Note 4).

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (Topic 815), which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. In April 2019, the FASB issued ASU 2019-04, which provides clarifications and minor improvements related to Topic 815. Adoption of this guidance in the first quarter of fiscal 2020 did not have a material impact on our consolidated financial statements.

Note 3 – Revenue Recognition

We adopted the provisions of ASU 2014-9 in the first quarter of fiscal 2019, and we elected to adopt the standard using the retrospective method. The core principle of the guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. 

Our revenue is primarily generated from the sale of non-customized consumer products to customers. Revenue is recognized when control of, and title to, the product sold transfers to the customer. Therefore, the timing and amount of revenue recognized was not materially impacted by the new guidance. We have thus concluded that the adoption of the guidance did not have a material impact on our consolidated financial statements. The provisions of the new guidance did however impact the classification of certain consideration paid to our customers. We therefore reclassified an immaterial amount of such payments from SG&A to a reduction of net sales revenue for all periods presented. Also,

8

in accordance with the guidance, we reclassified an immaterial amount of estimated sales returns from a reduction of receivables to accrued expenses and other current liabilities for all periods presented.  We elected to adopt the guidance using the full retrospective method. 

We measure revenue as the amount of consideration for which we expect to be entitled, in exchange for transferring goods.  Certain customers may receive cash incentives such as customer discounts (including volume or trade discounts), advertising discounts and other customer-related programs which are accounted for as variable consideration.  In some cases, we apply judgment, such as contractual rates and historical payment trends, when estimating variable consideration.  In accordance with the guidance, most variable consideration is classified as a reduction to net sales.

Sales taxes and other similar taxes are excluded from revenue.  We elected to account for shipping and handling activities as a fulfillment cost as permitted by the guidance.  We do not have unsatisfied performance obligations since our performance obligations are satisfied at a single point in time.

Note 4 – Leases

Adoption of the new lease standard resulted in the recording of lease assets and lease liabilities of approximately $37.1 million and $47.2 million, respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to unamortized lease incentives and deferred rent recorded in accordance with the previous lease guidance. The new standard did not materially impact our consolidated statements of income or cash flows.

The Company primarily has leases for office space, which are classified as operating leases. Operating leases are included in operating lease assets, accrued expenses and other current liabilities, and lease liabilities, non-current in our consolidated balance sheets. Operating lease assets and operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As most of our lease contracts do not provide an explicit interest rate, we use an estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

We include options to extend or terminate the lease in the lease term for accounting considerations, when it is reasonably certain that we will exercise that option. Our leases have remaining lease terms of 1 to 14 years.  Lease expense for lease payments is recognized on a straight-line basis over the lease term in a manner similar to previous accounting guidance. We do not recognize leases with an initial term of twelve months or less on the balance sheet and instead recognize the related lease payments as expense in the condensed consolidated statements of income on a straight-line basis over the lease term. We account for lease and non-lease components as a single lease component for all asset classes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Under the new guidance, operating lease expense recognized in the condensed consolidated statements of income during the three and six month periods ended August 31, 2019 was $1.7 million and $3.3 million, respectively.  Short-term lease expense is excluded from this amount and is not material.  The non-cash component of lease expense is included as an adjustment to reconcile income from continuing operations to net cash provided by operating activities in the condensed consolidated statements of cash flows.

9

A summary of supplemental lease information is as follows:

	August 31, 2019
Weighted average remaining lease term (years)	11.1
Weighted average discount rate	6.09		%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,112

A summary of our estimated lease payments, imputed interest and liabilities are as follows:

(in thousands)
Fiscal 2020 (balance for remainder of fiscal year)	$	2,470
Fiscal 2021	6,082
Fiscal 2022	5,959
Fiscal 2023	5,601
Fiscal 2024	5,102
Thereafter	40,132
Total future lease payments	65,346
Less: imputed interest	(19,721		)
Present value of lease liability	$	45,625

	August 31, 2019
Lease liabilities, current (1)	$	3,155
Lease liabilities, non-current	42,470
Total lease liability	$	45,625

^{(1) Included as part of "Accrued expenses and other current liabilities" on the condensed consolidated balance sheet.}  

Note 5 – Discontinued Operations

In December 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries ("Healthy Directions") to Direct Digital, LLC. The purchase price from the sale was comprised of $46.0 million in cash, which was paid at closing, and a supplemental payment with a target value of $25.0 million, payable on or before August 1, 2019.  During fiscal 2019, the final amount of the supplemental payment was adjusted to $10.8 million based on a settlement with respect to the calculation of the performance of Healthy Directions through February 28, 2018. The adjustment resulted in a corresponding pre-tax charge of $5.8 million ($4.4 million after tax) to discontinued operations. The supplemental payment of $10.8 million was received during the second quarter of fiscal 2020. Also, during fiscal 2019, we recorded additional net charges of $1.5 million ($1.3 million after tax) to discontinued operations, resulting from the resolution of certain contingencies. In conjunction with the sale of the business, we provided certain transition services that ceased during the second quarter of fiscal 2020.

10

Note 6 – Supplemental Balance Sheet Information

PROPERTY AND EQUIPMENT

(in thousands)	Estimated Useful Lives (Years)			August 31, 2019			February 28, 2019
Land		-		$	12,644		$	12,644
Building and improvements	3	-	40	113,619			113,820
Computer, software, furniture and other equipment	3	-	15	86,699			84,711
Tools, molds and other production equipment	3	-	7	37,000			36,378
Construction in progress		-		11,261			6,529
Property and equipment, gross				261,223			254,082
Less accumulated depreciation				(130,059		)	(123,744		)
Property and equipment, net				$	131,164		$	130,338

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 

(in thousands)	August 31, 2019		February 28, 2019
Accrued compensation, benefits and payroll taxes	$	29,159	$	36,782
Accrued sales discounts and allowances	28,924		28,655
Accrued sales returns	21,359		23,316
Accrued advertising	28,060		26,549
Other	41,769		49,858
Total accrued expenses and other current liabilities	$	149,271	$	165,160

Note 7 – Goodwill and Intangible Assets

We perform annual impairment tests each fiscal year during the fourth quarter and interim impairment tests, if and when necessary. For the three and six month periods ended August 31, 2019 and 2018, we did not record any impairment charges.

11

The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented:

	August 31, 2019										February 28, 2019
(in thousands)	Gross Carrying Amount		Cumulative Goodwill Impairments			Accumulated Amortization			Net Book Value		Gross Carrying Amount		Cumulative Goodwill Impairments			Accumulated Amortization			Net Book Value
Housewares:
Goodwill	$	282,056	$	—		$	—		$	282,056	$	282,056	$	—		$	—		$	282,056
Trademarks - indefinite	134,200		—			—			134,200		134,200		—			—			134,200
Other intangibles - finite	41,328		—			(20,066		)	21,262		41,417		—			(19,398		)	22,019
Subtotal	457,584		—			(20,066		)	437,518		457,673		—			(19,398		)	438,275
Health & Home:
Goodwill	284,913		—			—			284,913		284,913		—			—			284,913
Trademarks - indefinite	54,000		—			—			54,000		54,000		—			—			54,000
Licenses - finite	17,050		—			(15,577		)	1,473		17,050		—			(15,402		)	1,648
Licenses - indefinite	7,400		—			—			7,400		7,400		—			—			7,400
Other intangibles - finite	118,024		—			(93,373		)	24,651		117,967		—			(87,953		)	30,014
Subtotal	481,387		—			(108,950		)	372,437		481,330		—			(103,355		)	377,975
Beauty:
Goodwill	81,841		(46,490		)	—			35,351		81,841		(46,490		)	—			35,351
Trademarks - indefinite	—		—			—			—		30,407		—			—			30,407
Trademarks - finite	30,557		—			(1,956		)	28,601		150		—			(102		)	48
Licenses - indefinite	10,300		—			—			10,300		10,300		—			—			10,300
Licenses - finite	13,696		—			(12,641		)	1,055		13,696		—			(12,482		)	1,214
Other intangibles - finite	46,402		—			(46,158		)	244		46,402		—			(46,126		)	276
Subtotal	182,796		(46,490		)	(60,755		)	75,551		182,796		(46,490		)	(58,710		)	77,596
Total	$	1,121,767	$	(46,490	)	$	(189,771	)	$	885,506	$	1,121,799	$	(46,490	)	$	(181,463	)	$	893,846

After discontinuing the formal sale process and revising the strategic initiatives for our Personal Care business during the first quarter of fiscal year 2020, we changed trademarks related to the business with a net book value of $30.4 million from indefinite lived to finite lived assets. The amortization of these trademarks is now included in amortization expense for the six months ended August 31, 2019, and these assets are expected to be fully amortized by the end of fiscal year 2027.

The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2020 through 2025:

Aggregate Amortization Expense
For the three months ended (in thousands)
August 31, 2019	$	4,463
August 31, 2018	3,402

Aggregate Amortization Expense
For the six months ended (in thousands)
August 31, 2019	$	8,339
August 31, 2018	7,522

12

Estimated Amortization Expense (in thousands)
Fiscal 2020	$	17,691
Fiscal 2021	16,135
Fiscal 2022	9,037
Fiscal 2023	8,847
Fiscal 2024	8,441
Fiscal 2025	6,977

Note 8 – Share-Based Compensation Plans

We have equity awards outstanding under several share-based compensation plans. During the three and six months ended August 31, 2019, we had the following share-based compensation activity:

• We issued 1,048 and 2,304 shares to non-employee Board members with a total grant date fair value of $0.1 and $0.2 million, respectively, and share prices of $134.21 and $121.99, respectively.

• We granted time-vested restricted stock units ("RSUs") that may be settled for 8 and 3,279 shares of common stock, respectively. The RSU grants have a weighted average grant price of $150.86 and $111.51 per share, respectively. For the three months ended August 31, 2019, the total award fair value was insignificant. For the six months ended August 31, 2019, the total award fair value at date of grant was $0.4 million.

• We granted time-vested restricted stock awards ("RSAs") that may be vested for 4,920 and 45,772 shares of common stock, respectively. The RSA grants have a weighted average grant price of $138.86 and $113.98 per share, respectively, for a total award fair value at date of grant of $0.7 million and $5.2 million, respectively.

• There were no grants of performance-based stock units ("PSUs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSUs that may be settled for 6,088 shares of common stock. The PSU grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $0.7 million.

• There were no grants of performance-based restricted stock awards ("PSAs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSAs that are targeted to be vested for 122,402 shares of common stock. The PSA grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $13.6 million.

• RSUs for 3,489 and 66,329 shares vested and settled, respectively, with a total fair value at settlement of $0.5 and $7.6 million and a weighted average share price of $146.26 and $114.58, respectively.  

• There were no PSUs shares vested and settled during the three months ended August 31, 2019. For the six months ended August 31, 2019, there were 108,572 shares vested and settled with a total fair value at settlement of $14.7 million, and a weighted average share price of $135.85.

• RSAs for 928 shares vested and settled with a total fair value at settlement of $0.1 million and a weighted average share price of $150.86 during the three and six month periods ended August 31, 2019.

13

• Employees exercised stock options to purchase 26,368 and 61,765 shares of common stock, respectively.

• There were no purchases of common stock under the employee stock purchase plan during the three months ended August 31, 2019. For the six months ended August 31, 2019, employees purchased 14,790 shares of common stock under the employee stock purchase plan at an average price of $95.29 per share.

We recorded the following share-based compensation expense in SG&A for the periods shown below: 

	Three Months Ended August 31,
(in thousands, except per share data)	2019			2018
Stock options	$	35		$	219
Directors stock compensation	141			123
Performance based and other stock awards	6,205			4,347
Employee stock purchase plan	—			—
Share-based compensation expense	6,381			4,689
Less income tax benefits	(514		)	(341		)
Share-based compensation expense, net of income tax benefits	$	5,867		$	4,348
Impact of share-based compensation on earnings per share from continuing operations:
Basic	$	0.23		$	0.16
Diluted	$	0.23		$	0.16

	Six Months Ended August 31,
(in thousands, except per share data)	2019			2018
Stock options	$	151		$	527
Directors stock compensation	281			246
Performance based and other stock awards	13,228			9,918
Employee stock purchase plan	325			322
Share-based compensation expense	13,985			11,013
Less income tax benefits	(1,091		)	(611		)
Share-based compensation expense, net of income tax benefits	$	12,894		$	10,402
Impact of share-based compensation on earnings per share from continuing operations:
Basic	$	0.51		$	0.39
Diluted	$	0.51		$	0.39

Note 9 – Repurchase of Helen of Troy Common Stock

On May 20, 2019, we announced that our Board of Directors had authorized the repurchase of up to $400 million of our outstanding common stock.  The authorization is effective May 8, 2019 for a period of three years and replaced Helen of Troy's previous repurchase authorization, of which approximately $107.4 million remained. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities.  As of August 31, 2019, our repurchase authorization allowed for the purchase of $394.0 million of common stock. 

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants.  In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the equity holder can be paid for by having the equity holder tender back to the Company a number of shares at fair value equal to the amounts due.  Net exercises are treated as purchases and retirements of shares.

14

The following table summarizes our share repurchase activity for the periods shown:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands, except share and per share data)	2019		2018		2019		2018
Common stock repurchased on the open market:
Number of shares	—		—		—		407,025
Aggregate value of shares	$	—	$	—	$	—	$	37,067
Average price per share	$	—	$	—	$	—	$	91.07
Common stock received in connection with share-based compensation:
Number of shares	2,354		7,477		70,558		57,072
Aggregate value of shares	$	344	$	692	$	9,131	$	5,173
Average price per share	$	145.96	$	92.55	$	129.42	$	90.65

Note 10 – Restructuring Plan

In October 2017, we announced that we had approved a restructuring plan (referred to as “Project Refuel”). Project Refuel includes a reduction-in-force and the elimination of certain contracts and operating expenses.  We are targeting total annualized profit improvements of approximately $8.0 to $10.0 million over the duration of the plan.  We estimate the plan will be completed during fiscal 2020, and expect to incur total restructuring charges of approximately $7.0 million over the duration of the plan. Restructuring provisions are determined based on estimates prepared at the time the restructuring actions are approved by management and are revised periodically.

For the three and six month periods ended August 31, 2019, we incurred $0.4 million and $1.0 million, respectively, of pre-tax restructuring charges related primarily to employee severance and termination benefits and lease termination costs. Since implementing Project Refuel, we have incurred $6.4 million of pre-tax restructuring costs related to employee severance and termination benefits and contract termination costs as of August 31, 2019. During the three and six month periods ended August 31, 2019, we made total cash restructuring payments of $0.9 million and $1.5 million, respectively. Since implementing Project Refuel, we have made total cash restructuring payments of $5.8 million. We had a remaining liability of $0.7 million as of August 31, 2019.

Note 11 – Commitments and Contingencies

Legal Matters – On May 31, 2018, we settled a patent infringement dispute related to two forehead thermometer models sold by our subsidiary, Kaz USA, Inc., in the United States and made a settlement payment of $15.0 million, which was accrued in prior periods along with related legal fees and other costs.      

We are involved in various other legal claims and proceedings in the normal course of operations.  We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

15

Lease Commitments – The implementation of the new lease guidance (ASC 842) using the effective date method requires the disclosure of our lease commitments from our latest annual report on Form 10-K for the interim periods during the first year of adoption (see Note 4). The lease commitments as of February 28, 2019 were as follows:

	Fiscal Years Ended the Last Day of February:
			2020		2021		2022		2023		2024		After
(in thousands)	Total		1 year		2 years		3 years		4 years		5 years		5 years
Operating leases	$	69,482	$	5,171	$	6,678	$	6,411	$	5,743	$	5,078	$	40,401

The minimum rental payments for operating leases presented above were determined in accordance with the previous lease guidance (ASC 840). Note 4 presents a summary of our estimated lease payments, imputed interest and liabilities as of August 31, 2019, in accordance with the new lease guidance (ASC 842).

Note 12 – Long-Term Debt

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provided for an unsecured total revolving commitment of $1.0 billion as of August 31, 2019. The commitment under the Credit Agreement terminates on December 7, 2021. Borrowings accrue interest under one of two alternative methods (based upon a base rate of LIBOR) as described in the Credit Agreement. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time.  We also incur loan commitment fees and letter of credit fees under the Credit Agreement.  Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis.  As of August 31, 2019, the outstanding revolving loan principal balance was $283.0 million (excluding prepaid financing fees) and the face amount of outstanding letters of credit was $9.0 million. For the three and six month periods ended August 31, 2019, borrowings under the Credit Agreement incurred interest charges at rates ranging from 3.1% to 5.5%. For the three and six month periods ended August 31, 2018, borrowings under the Credit Agreement incurred interest charges at rates ranging from 2.9% to 5.0% and 2.8% to 5.0%, respectively. As of August 31, 2019, the amount available for borrowings under the Credit Agreement was $708.0 million. Covenants in our debt agreements limit the amount of total indebtedness we can incur.  As of August 31, 2019, these covenants effectively limited our ability to incur more than $609.0 million of additional debt from all sources, including our Credit Agreement, or $708.0 million in the event a qualified acquisition is consummated.  The following table summarizes our long-term debt as of the end of the periods shown:

(in thousands)	Original Date Borrowed	Interest Rates	Matures	August 31, 2019			February 28, 2019
Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1)	03/13	Floating	03/23	$	20,443		$	22,335
Credit Agreement (2)	01/15	Floating	12/21	280,750			298,449
Total long-term debt				301,193			320,784
Less current maturities of long-term debt				(1,884		)	(1,884		)
Long-term debt, excluding current maturities				$	299,309		$	318,900

(1) The MBFC Loan is unsecured with an original balance of $37.6 million and incurs floating interest based on applicable LIBOR plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder’s call on or after March 1, 2018.  The loan can be prepaid without penalty.  The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and $14.8 million on March 1, 2023.  Any remaining outstanding principal and interest is due upon maturity on March 1, 2023.

16

(2) Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement.  Notes 13 and 14 to these condensed consolidated financial statements provide additional information regarding the interest rate swaps.

At August 31, 2019 and February 28, 2019, our long-term debt has floating interest rates, and its book value approximates its fair value. 

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries.  Our debt agreements require the maintenance of certain financial covenants, including a maximum leverage ratio and a minimum interest coverage ratio (as each of these terms is defined in the agreements).  Our debt agreements also contain other customary covenants.  We were in compliance with the terms of these agreements as of August 31, 2019.

Note 13 – Fair Value 

We classify our various assets and liabilities recorded or reported at fair value under a hierarchy prescribed by GAAP that prioritizes inputs to fair value measurement techniques into three broad levels:

Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets;

Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

Assets and liabilities subject to classification are classified upon acquisition.  When circumstances dictate the transfer of an asset or liability to a different level, our policy is to recognize the transfer at the beginning of the reporting period in which the event resulting in the transfer occurred.

The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown:

	Fair Values at
	August 31, 2019
(in thousands)	(Level 2) (1)
Assets:
Money market accounts	$	1,232
Interest rate swaps	—
Foreign currency contracts	3,482
Total assets	$	4,714
Liabilities:
Floating rate debt	$	301,193
Interest rate swaps	9,152
Foreign currency contracts	—
Total liabilities	$	310,345

17

	Fair Values at
	February 28, 2019
(in thousands)	(Level 2) (1)
Assets:
Money market accounts	$	915
Interest rate swaps	512
Foreign currency contracts	1,692
Total assets	$	3,119
Liabilities:
Floating rate debt	$	320,784
Interest rate swaps	339
Foreign currency contracts	563
Total liabilities	$	321,686

(1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable.

The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items.

We use derivatives for hedging purposes and our derivatives are primarily interest rate swaps, foreign currency contracts and cross-currency debt swaps.  See Notes 12 and 14 to these condensed consolidated financial statements for more information on our hedging activities.

We classify our floating rate debt as a Level 2 item because the estimation of the fair market value requires the use of a discount rate based upon current market rates of interest for obligations with comparable remaining terms.  Such comparable rates are considered significant other observable market inputs.  The book value of the floating rate debt approximates its fair value as of the reporting date.

Our other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 items.  These assets are measured at fair value on a non-recurring basis as part of our impairment testing.  Note 7 to these condensed consolidated financial statements contains additional information related to intangible asset impairments.

Note 14 – Financial Instruments and Risk Management

Foreign Currency Risk - Our functional currency is the U.S. Dollar.  By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses.  As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three and six month periods ended August 31, 2019, approximately 14% and 13% of our net sales revenue was in foreign currencies, respectively. During the three and six month periods ended August 31, 2018, approximately 11% and 13% of our net sales revenue was in foreign currencies, respectively. These sales were primarily denominated in Euros, British Pounds, Canadian Dollars, and Mexican Pesos. We make most of our inventory purchases from the Far East and primarily use the U.S. Dollar for such purchases.

In our condensed consolidated statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities are recognized in their respective income tax lines, and all other foreign exchange gains and losses are recognized in SG&A.  During the three and six month periods ended August 31, 2019, we recorded net foreign exchange gains from remeasurement, including the impact of currency hedges and the cross-currency debt swaps, of $0.8 million and $1.6 million, respectively, in SG&A. We recorded net foreign

18

exchange gains from remeasurement, including the impact of foreign currency hedges and cross currency debt swaps of $0.5 million and losses of $1.2 million in SG&A during the three and six month periods ended August 31, 2018, respectively.

We hedge against certain foreign currency exchange rate-risk by using a series of forward contracts and zero-cost collars designated as cash flow hedges and mark-to-market derivatives to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar. We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes. The effective portion of the changes in fair value of these instruments is reported in OCI and reclassified into SG&A in the same period they are settled. The ineffective portion, which is not material for any year presented, is immediately recognized in SG&A.

Interest Rate Risk - Interest on our outstanding debt as of August 31, 2019 is based on floating interest rates.  If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225.0 million of the outstanding principal balance under the Credit Agreement, which totaled $283.0 million (excluding prepaid finance fees) as of August 31, 2019.

The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:

(in thousands)	August 31, 2019
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- current
Zero-cost dollar - Euro	Cash flow	02/2021	€	16,000	$	207	$	31	$	—	$	—
Foreign currency contracts - sell Euro	Cash flow	12/2020	€	12,750	661		89		—		—
Foreign currency contracts - sell Canadian Dollars	Cash flow	01/2021	$	14,250	125		8		—		—
Zero-cost dollar - Pound	Cash flow	02/2021	£	10,250	237		49		—		—
Foreign currency contracts - sell Pound	Cash flow	02/2021	£	13,500	1,086		195		—		—
Foreign currency contracts - sell Mexican Pesos	Cash flow	02/2020	$	40,000	13		—		—		—
Foreign currency contracts - Sell Australian Dollars	Cash flow	10/2019	$	2,000	46		—		—		—
Interest rate swaps	Cash flow	01/2024	$	225,000	—		—		2,513		6,639
Subtotal					2,375		372		2,513		6,639
Derivatives not designated under hedge accounting
Foreign currency contracts - cross-currency debt swaps - Euro	(1)	04/2020	€	5,280	431		—		—		—
Foreign currency contracts - cross-currency debt swaps - Pound	(1)	04/2020	£	6,395	304		—		—		—
Subtotal					735		—		—		—
Total fair value					$	3,110	$	372	$	2,513	$	6,639

19

(in thousands)	February 28, 2019
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- current
Zero-cost dollar - Euro	Cash flow	02/2020	€	9,500	$	11	$	—	$	—	$	—
Foreign currency contracts - sell Euro	Cash flow	01/2020	€	29,000	1,047		—		—		—
Foreign currency contracts - sell Canadian Dollars	Cash flow	02/2020	$	16,000	168		—		—		—
Zero-cost dollar - Pound	Cash flow	05/2020	£	4,500	—		—		200		—
Foreign currency contracts - sell Pound	Cash flow	05/2020	£	19,500	248		—		—		13
Foreign currency contracts - sell Mexican Pesos	Cash flow	09/2019	$	30,000	—		—		58		—
Interest rate swaps	Cash flow	01/2024	$	225,000	512		—		—		339
Subtotal					1,986		—		258		352
Derivatives not designated under hedge accounting
Foreign currency contracts - cross-currency debt swaps - Euro	(1)	04/2020	€	5,280	—		218		—		—
Foreign currency contracts - cross-currency debt swaps - Pound	(1)	04/2020	£	6,395	—		—		—		292
Subtotal					—		218		—		292
Total fair value					$	1,986	$	218	$	258	$	644

(1) These are foreign currency contracts for which we have not elected hedge accounting.  We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. 

The following table summarizes the pre-tax effect of derivative instruments for the periods shown:

	Three Months Ended August 31,
	Gain (Loss) Recognized in OCI (effective portion)						Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income							Gain (Loss) Recognized As Income
(in thousands)	2019			2018			Location	2019			2018			Location	2019		2018
Currency contracts - cash flow hedges	$	(482	)	$	(51	)	SG&A	$	(992	)	$	(610	)		$	—	$	—
Interest rate swaps - cash flow hedges	(4,126		)	137			Interest expense	—			—			Interest expense	77		136
Cross-currency debt swaps - principal	—			—				—			—			SG&A	344		243
Cross-currency debt swaps - interest	—			—				—			—			Interest Expense	—		—
Total	$	(4,608	)	$	86			$	(992	)	$	(610	)		$	421	$	379

	Six Months Ended August 31,
	Gain (Loss) Recognized in OCI (effective portion)					Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income						Gain (Loss) Recognized As Income
(in thousands)	2019			2018		Location	2019			2018		Location	2019		2018
Currency contracts - cash flow hedges	$	(668	)	$	4,525	SG&A	$	(2,210	)	$	77		$	—	$	—
Interest rate swaps - cash flow hedges	(9,326		)	76		Interest expense	—			—		Interest expense	231		211
Cross-currency debt swaps - principal	—			—			—			—		SG&A	808		666
Cross-currency debt swaps - interest	—			—			—			—		Interest expense	74		74
Total	$	(9,994	)	$	4,601		$	(2,210	)	$	77		$	1,113	$	951

We expect pre-tax losses of $0.1 million associated with foreign currency contracts and interest rate swaps currently reported in accumulated other comprehensive income, to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle. 

Counterparty Credit Risk - Financial instruments, including foreign currency contracts and cross currency debt swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. Although our

20

theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit losses is remote.

Note 15 – Accumulated Other Comprehensive Income (Loss)

The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown:

(in thousands)	Interest Rate Swaps			Foreign Currency Contracts			Total
Balance at February 28, 2018	$	1,705		$	(1,074	)	$	631
Other comprehensive income (loss) before reclassification	76			4,525			4,601
Amounts reclassified out of accumulated other comprehensive income	—			(77		)	(77		)
Tax effects	129			(637		)	(508		)
Other comprehensive income (loss)	205			3,811			4,016
Balance at August 31, 2018	$	1,910		$	2,737		$	4,647
Balance at February 28, 2019	$	132		$	1,059		$	1,191
Other comprehensive income (loss) before reclassification	(9,326		)	(668		)	(9,994		)
Amounts reclassified out of accumulated other comprehensive income	—			2,210			2,210
Tax effects	2,165			(327		)	1,838
Other comprehensive income (loss)	(7,161		)	1,215			(5,946		)
Balance at August 31, 2019	$	(7,029	)	$	2,274		$	(4,755	)

See Notes 12, 13 and 14 to these condensed consolidated financial statements for additional information regarding our hedging activities.

Note 16 – Segment Information

The following tables present segment information included in continuing operations for the periods shown:

	Three Months Ended August 31, 2019
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	167,864	$	158,790	$	87,341	$	413,995
Restructuring charges	2		—		428		430
Operating income	35,698		12,408		6,414		54,520
Capital and intangible asset expenditures	3,215		1,518		410		5,143
Depreciation and amortization	1,416		4,269		2,664		8,349

	Three Months Ended August 31, 2018
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	137,498	$	175,783	$	80,267	$	393,548
Restructuring charges	—		—		859		859
Operating income	28,329		13,631		8,700		50,660
Capital and intangible asset expenditures	5,642		2,466		771		8,879
Depreciation and amortization	1,522		4,229		1,562		7,313

21

	Six Months Ended August 31, 2019
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	312,806	$	313,733	$	163,791	$	790,330
Restructuring charges	90		—		959		1,049
Operating income	66,898		27,464		7,365		101,727
Capital and intangible asset expenditures	6,082		2,198		581		8,861
Depreciation and amortization	3,029		8,582		4,505		16,116

	Six Months Ended August 31, 2018
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	254,801	$	339,214	$	154,212	$	748,227
Restructuring charges	760		358		1,466		2,584
Operating income	50,512		33,288		10,187		93,987
Capital and intangible asset expenditures	7,296		4,655		1,110		13,061
Depreciation and amortization	3,006		8,377		3,912		15,295

We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, restructuring charges, and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus shared service and corporate overhead expenses that are allocable to the segment.  We do not allocate non-operating income and expense, including interest or income taxes, to operating segments.

Note 17 – Income Taxes

Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate.

For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items.

For the three months ended August 31, 2019, income tax expense as a percentage of income before income tax was 10.3% compared to 8.3% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates.

For the six months ended August 31, 2019, income tax expense as a percentage of income before income tax was 9.0%, which included $0.8 million of tax benefits from share-based compensation settlements, $1.7 million of expense from the remeasurement of deferred taxes due to tax rate changes, and a $2.8 million benefit from the resolution of an uncertain tax position. Income tax expense as a percentage of income before income tax was 7.3% for the same period last year, which included $0.5 million tax benefits from share-based compensation settlements and a $0.8 million benefit from the lapse of the statute of limitations related to an uncertain tax position. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates.

22

During fiscal 2017, we received an assessment from a state tax authority which adjusted taxable income applicable to the particular state resulting from interpretations of certain state income tax provisions applicable to our legal structure.  We believe we have accurately reported our taxable income and are vigorously protesting the assessment through administrative processes with the state.  We believe it is unlikely that the outcome of these matters will have a material adverse effect on our consolidated financial position, results of operations, or liquidity.

Our Macau subsidiary generates income from the sale of the goods that it has sourced and procured. This subsidiary is responsible for the sourcing and procurement of a large portion of the products that we sell. We currently have an indefinite tax holiday in Macau conditioned on the subsidiary meeting certain employment and investment thresholds. The Macau Offshore Law and its supplementary regulations that grant tax incentives to approved offshore institutions will be abolished on January 1, 2021. Existing approved offshore institutions such as ours can continue to operate under the offshore regime until the end of the calendar year 2020. Beginning in calendar year 2021, we believe our Macau subsidiary will become subject to a statutory corporate income tax of approximately 12%. The ultimate impact of this change, if any, on our overall effective tax rate will depend on a variety of factors including our mix of income by jurisdiction, transfer pricing considerations and the specific tax regulations applicable to us when we are no longer under the Macau Offshore regime. It is not practicable for us to determine the potential impact on our financial statements until the tax changes in Macau are fully established and our transfer pricing analysis is complete. Because our Macau subsidiary is not directly or indirectly owned by a U.S. parent, there is no U.S. tax liability associated with the income generated in Macau.

Note 18 – Earnings per Share

We compute basic earnings per share using the weighted average number of shares of common stock

outstanding during the period.  We compute diluted earnings per share using the weighted average

number of shares of common stock outstanding plus the effect of dilutive securities.  Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested RSUs, PSUs, RSAs, PSAs and other stock based awards.  See Note 8 to these condensed consolidated financial statements for more information regarding stock-based awards.  Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. 

The following table presents our weighted average basic and diluted shares for the periods shown:

	Three Months Ended August 31,		Six Months Ended August 31,
(in thousands)	2019	2018	2019	2018
Weighted average shares outstanding, basic	25,116	26,359	25,068	26,467
Incremental shares from share-based compensation arrangements	129	198	177	145
Weighted average shares outstanding, diluted	25,245	26,557	25,245	26,612
Antidilutive securities	166	194	259	352

23

ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) contains a number of forward-looking statements, all of which are based on current expectations. Actual results may differ materially due to a number of factors, including those discussed in Part I, Item 3. “Quantitative and Qualitative Disclosures about Market Risk” and “Information Regarding Forward-Looking Statements” in this report and “Risk Factors” in the Company’s most recent annual report on Form 10-K for the fiscal year ended February 28, 2019 (“Form 10-K”) and its other filings with the Securities and Exchange Commission (the “SEC”). This discussion should be read in conjunction with our condensed consolidated financial statements included under Part I, Item 1. of this report. When used in the MD&A, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. Throughout MD&A, we refer to our Leadership Brands, which are brands that have number-one and number-two positions in their respective categories and consist of the OXO, Honeywell, Braun, PUR, Hydro Flask, Vicks, and Hot Tools brands.

This MD&A, including the tables under the headings “Operating income, operating margin, adjusted operating income (non-GAAP) and adjusted operating margin (non-GAAP) by segment" and “Income from continuing operations, diluted EPS from continuing operations, adjusted income from continuing operations (non-GAAP), and adjusted diluted EPS from continuing operations (non-GAAP),” respectively, reports operating income, operating margin, income from continuing operations and diluted earnings per share ("EPS") from continuing operations without the impact of non-cash asset impairment charges, restructuring charges, amortization of intangible assets, and non-cash share-based compensation for the periods presented, as applicable. These measures may be considered non-GAAP financial information as set forth in SEC Regulation G, Rule 100. The tables reconcile these measures to their corresponding GAAP-based measures presented in our condensed consolidated statements of income. We believe that adjusted operating income, adjusted operating margin, adjusted income from continuing operations, and adjusted diluted EPS from continuing operations provide useful information to management and investors regarding financial and business trends relating to our financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with our financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of such charges on applicable income, margin and earnings per share measures. We also believe that these non-GAAP measures facilitate a more direct comparison of our performance to our competitors. We further believe that including the excluded charges would not accurately reflect the underlying performance of our continuing operations for the period in which the charges are incurred, even though such charges may be incurred and reflected in our GAAP financial results in the near future. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of our activities. Our adjusted operating income, adjusted operating margin, adjusted income from continuing operations, and adjusted diluted EPS from continuing operations are not prepared in accordance with GAAP, are not an alternative to GAAP financial information and may be calculated differently than non-GAAP financial information disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP information.

These measures are discussed further and reconciled to their applicable GAAP based measures contained in this MD&A beginning on page 36. 

24

OVERVIEW

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994.  We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of well-recognized and widely-trusted brands.  We have built leading market positions through new product innovation, product quality and competitive pricing.  We currently operate in three segments consisting of Housewares, Health & Home, and Beauty.  

In fiscal 2015, we launched a five-year transformational strategy designed to improve the performance of our business segments and strengthen our shared service capabilities.  Fiscal 2019 marked the completion of Phase I of our multi-year transformation strategy, which delivered performance across a wide range of measures. We improved core sales growth by focusing on our Leadership Brands, made strategic acquisitions, became a more efficient operating company with strong global shared services, upgraded our organization and culture, improved inventory turns and return on invested capital, and returned capital to shareholders.

Fiscal 2020 begins Phase II of our transformation and is designed to drive the next five years of progress. The long-term objectives of Phase II include improved organic sales growth, continued margin expansion, and strategic and effective capital deployment. We expect Phase II will include continued investment in our Leadership Brands, with a focus on growing them through consumer-centric innovation, expanding them more aggressively outside the United States, and adding new brands through acquisition. We anticipate building further shared service capability and operating efficiency, as well as attracting, retaining, unifying and training the best people.

In December 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries ("Healthy Directions") to Direct Digital, LLC. The purchase price from the sale was comprised of $46.0 million in cash, which was paid at closing, and a supplemental payment with a target value of $25.0 million, payable on or before August 1, 2019. The final amount of the supplemental payment was adjusted based on a settlement with respect to the calculation of the performance of Healthy Directions through February 28, 2018. During fiscal 2019, we reduced the estimated value of the supplemental payment to $10.8 million and recorded a corresponding pre-tax charge of $5.8 million ($4.4 million after tax) to discontinued operations. The supplemental payment of $10.8 million was received during the second quarter of fiscal 2020. Also, during fiscal 2019, we recorded an additional charge of $1.5 million ($1.3 million after tax) to discontinued operations, resulting from the resolution of certain contingencies. In conjunction with the sale of the business, we provided certain transition services that ceased during the second quarter of fiscal 2020. Following the sale, we no longer consolidate our former Nutritional Supplements segment's operating results. Unless otherwise indicated, all results presented are from continuing operations.

In fiscal 2018, we announced that we had approved a restructuring plan (“Project Refuel”). Project Refuel includes a reduction-in-force and the elimination of certain contracts and operating expenses. We are targeting total annualized profit improvements of approximately $8.0 to $10.0 million over the duration of the plan.  We estimate the plan will be completed during fiscal 2020, and expect to incur total restructuring charges of approximately $7.0 million over the duration of the plan. Since implementing Project Refuel, we have incurred $6.4 million of pre-tax restructuring costs related to employee severance and termination benefits and contract termination costs as of August 31, 2019. For additional information regarding Project Refuel, see Note 10 to the accompanying condensed consolidated financial statements.

25

Significant Trends Impacting the Business

Impact of Tariffs

During fiscal years 2019 and 2020, the Office of the U.S. Trade Representative (‘‘USTR’’) has imposed additional tariffs on products imported from China. We purchase a high concentration of our products from unaffiliated manufacturers located in China. This concentration exposes us to risks associated with doing business globally, including changes in tariffs.

The tariff increases that have been implemented by the USTR began to impact our cost of goods sold in the third quarter of fiscal 2019 and will continue to do so as new tariff increases go into effect. We expect to mitigate the impact of these tariffs primarily through pricing actions and product cost reductions in our supply chain. Although our pricing actions are intended to offset the gross profit dollar impact of tariff increases, there are no assurances that the pricing actions will not reduce retail consumption or customer orders in the short-term. Furthermore, the USTR has proposed additional tariff increases that have yet to take effect.

Potential Impact of Brexit and Offshore Receipts in Respect of Intangible Property Tax

The potential exit of the United Kingdom (the "U.K.") from European Union ("E.U.") membership (commonly referred to as "Brexit") could cause disruptions to and create uncertainty surrounding our business, including affecting our relationships with our existing and future customers, suppliers and employees, which could have an adverse effect on our business, financial results and operations. Negotiations are ongoing to determine the future terms of the U.K.’s relationship with the E.U., including the terms of trade between the U.K. and the E.U. The effects of Brexit will depend on any agreements the U.K. makes to retain access to E.U. markets either during a transitional period or more permanently. These measures could potentially disrupt the markets we serve and the tax jurisdictions in which we operate, adversely change tax benefits or liabilities in these or other jurisdictions, and cause us to lose customers, suppliers, and employees. In addition, Brexit could lead to legal uncertainty and potentially divergent national laws and regulations as the U.K. determines which E.U. laws to replace or replicate.

The U.K.’s Offshore Receipts in respect of Intangible Property (ORIP) rules were introduced by the Finance Act 2019 and came into effect on April 6, 2019. Under the ORIP rules, where intangible property (IP) is held in offshore companies, in a territory with which the U.K. does not have a full double taxation arrangement and the IP is used directly or indirectly to enable, facilitate or promote U.K. sales, income derived from that IP could be subject to a U.K. gross receipts tax at 20% of the gross amounts. Based on currently available information, the Company intends to treat this tax as a transactional tax included in operating expenses. Certain aspects of this legislation and its implementation remain unclear at this time and we expect that additional regulations or guidance may be issued and the accounting treatment of the new tax may be clarified.

While we do not believe the ORIP tax will have a material adverse impact on our consolidated operating results, we do believe that it could be material to the profitability of our EMEA operating unit. As a result, the ORIP tax could cause us to evaluate different strategic choices with respect to our EMEA operating unit, including a rationalization of the product portfolio sold in the U.K. or an exit from the market, which could adversely impact our net sales revenue.

Foreign Currency Exchange Rate Fluctuations 

Due to the nature of our operations, we have exposure to the impact of fluctuations in exchange rates from transactions that are denominated in a currency other than our reporting currency (the U.S. Dollar). The most significant currencies affecting our operating results are the British Pound, Euro, Canadian Dollar, and Mexican Peso.  

26

For the three months ended August 31, 2019, changes in foreign currency exchange rates had an unfavorable impact on consolidated U.S. Dollar reported net sales revenue of approximately $1.9 million, or 0.5%, compared to the unfavorable impact of $0.3 million, or 0.1% for the same period last year. For the six months ended August 31, 2019, changes in foreign currency exchange rates had an unfavorable impact on consolidated U.S. dollar reported net sales revenue of approximately $4.5 million, or 0.6%, compared to the favorable impact of $3.2 million, or 0.5% for the same period last year.

Consumer Spending and Changes in Shopping Preferences

Our business depends upon discretionary consumer demand for most of our products and primarily operates within mature and highly developed consumer markets. The principal driver of our operating performance is the strength of the U.S. retail economy. Approximately 80% of our net sales were from U.S. shipments for the three months ended August 31, 2019, compared to approximately 79% for the same period last year. For the six months ended August 31, 2019 and 2018, U.S. shipments were approximately 79% and 77% of our net sales, respectively.

Additionally, the shift in consumer shopping preferences to online or multichannel shopping experiences has changed the concentration of our sales. For the three and six month periods ended August 31, 2019, our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 24% and 23%, respectively, of our total consolidated net sales revenue, and grew approximately 25% and 26%, respectively, over the same periods last year.

For the three and six month periods ended August 31, 2018, our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 20% of our total consolidated net sales revenue, and grew approximately 34% and 38%, respectively, over the same periods last year.

With the continued growth in online sales across the retail landscape, many brick and mortar retailers are aggressively looking for ways to improve their customer delivery capabilities to be able to meet customer expectations.  As a result, it will become increasingly important for us to leverage our distribution capabilities in order to meet the changing demands of our customers, as well as to increase our online capabilities to support our direct-to-consumer sales channels and online channel sales by our retail customers. 

Variability of the Cough/Cold/Flu Season 

Sales in several of our Health & Home segment categories are highly correlated to the severity of winter weather and cough/cold/flu incidence. In the U.S., the cough/cold/flu season historically runs from November through March, with peak activity normally in January to March. For the 2018-2019 season, fall and winter weather was generally milder than historical averages and cough/cold/flu incidence was significantly lower than the 2017-2018 season, which was an above average season.

27

RESULTS OF OPERATIONS

The following tables provide selected operating data, in U.S. Dollars, as a percentage of net sales

revenue, and as a year-over-year percentage change:

	Three Months Ended August 31,											% of Sales Revenue, net
(in thousands)	2019			2018			$ Change			% Change		2019		2018
Sales revenue by segment, net
Housewares	$	167,864		$	137,498		$	30,366		22.1	%	40.5	%	34.9	%
Health & Home	158,790			175,783			(16,993		)	(9.7	)%	38.4	%	44.7	%
Beauty	87,341			80,267			7,074			8.8	%	21.1	%	20.4	%
Total sales revenue, net	413,995			393,548			20,447			5.2	%	100.0	%	100.0	%
Cost of goods sold	235,844			238,375			(2,531		)	(1.1	)%	57.0	%	60.6	%
Gross profit	178,151			155,173			22,978			14.8	%	43.0	%	39.4	%
Selling, general and administrative expense ("SG&A")	123,201			103,654			19,547			18.9	%	29.8	%	26.3	%
Restructuring charges	430			859			(429		)	(49.9	)%	0.1	%	0.2	%
Operating income	54,520			50,660			3,860			7.6	%	13.2	%	12.9	%
Non-operating income, net	89			85			4			4.7	%	—	%	—	%
Interest expense	(3,216		)	(2,755		)	(461		)	16.7	%	(0.8	)%	(0.7	)%
Income before income tax	51,393			47,990			3,403			7.1	%	12.4	%	12.2	%
Income tax expense	5,298			3,973			1,325			33.4	%	1.3	%	1.0	%
Income from continuing operations	46,095			44,017			2,078			4.7	%	11.1	%	11.2	%
Loss from discontinued operations (1)	—			—			—			*		—	%	—	%
Net income	$	46,095		$	44,017		$	2,078		4.7	%	11.1	%	11.2	%

	Six Months Ended August 31,											% of Sales Revenue, net
(in thousands)	2019			2018			$ Change			% Change		2019		2018
Sales revenue by segment, net
Housewares	$	312,806		$	254,801		$	58,005		22.8	%	39.6	%	34.1	%
Health & Home	313,733			339,214			(25,481		)	(7.5	)%	39.7	%	45.3	%
Beauty	163,791			154,212			9,579			6.2	%	20.7	%	20.6	%
Total sales revenue, net	790,330			748,227			42,103			5.6	%	100.0	%	100.0	%
Cost of goods sold	458,452			446,496			11,956			2.7	%	58.0	%	59.7	%
Gross profit	331,878			301,731			30,147			10.0	%	42.0	%	40.3	%
SG&A	229,102			205,160			23,942			11.7	%	29.0	%	27.4	%
Restructuring charges	1,049			2,584			(1,535		)	(59.4	)%	0.1	%	0.3	%
Operating income	101,727			93,987			7,740			8.2	%	12.9	%	12.6	%
Non-operating income, net	221			160			61			38.1	%	—	%	—	%
Interest expense	(6,524		)	(5,442		)	(1,082		)	19.9	%	(0.8	)%	(0.7	)%
Income before income tax	95,424			88,705			6,719			7.6	%	12.1	%	11.9	%
Income tax expense	8,635			6,515			2,120			32.5	%	1.1	%	0.9	%
Income from continuing operations	86,789			82,190			4,599			5.6	%	11.0	%	11.0	%
Loss from discontinued operations (1)	—			(381		)	381			*		—	%	(0.1	)%
Net income	$	86,789		$	81,809		$	4,980		6.1	%	11.0	%	10.9	%

(1) During fiscal 2018, we divested our Nutritional Supplements segment, which is reported as discontinued operations for all periods presented. For more information see Note 5 to the accompanying condensed consolidated financial statements.

* Calculation is not meaningful.

28

Second Quarter Fiscal 2020 Financial Results

• Consolidated net sales revenue increased 5.2%, or $20.4 million, to $414.0 million for the three months ended August 31, 2019, compared to $393.5 million for the same period last year.

• Consolidated operating income increased 7.6%, or $3.9 million, to $54.5 million for the three months ended August 31, 2019, compared to $50.7 million for the same period last year. Consolidated operating margin increased 0.3 percentage points to 13.2% of consolidated net sales revenue for the three months ended August 31, 2019, compared to 12.9% for the same period last year. The three months ended August 31, 2019 included pre-tax restructuring charges of $0.4 million compared to pre-tax restructuring charges of $0.9 million for the same period last year.  

• Consolidated adjusted operating income increased 10.4%, or $6.2 million, to $65.8 million for the three months ended August 31, 2019, compared to $59.6 million for the same period last year. Consolidated adjusted operating margin increased 0.8 percentage points to 15.9% of consolidated net sales revenue for the three months ended August 31, 2019, compared to 15.1% for the same period last year.

• Income from continuing operations increased 4.7%, or $2.1 million, to $46.1 million for the three months ended August 31, 2019, compared to $44.0 million for the same period last year. Diluted earnings per share ("EPS") from continuing operations increased 10.2% to $1.83 for the three months ended August 31, 2019, compared to $1.66 for the same period last year.

• Adjusted income from continuing operations increased 7.6%, or $4.0 million, to $56.5 million for the three months ended August 31, 2019, compared to $52.5 million for the same period last year. Adjusted diluted EPS from continuing operations increased 13.1% to $2.24 for the three months ended August 31, 2019, compared to $1.98 for the same period last year.

• There were no results from discontinued operations for either the three months ended August 31, 2019 or 2018.

Year-To-Date Fiscal 2020 Financial Results

• Consolidated net sales revenue increased 5.6%, or $42.1 million, to $790.3 million for the six months ended August 31, 2019, compared to $748.2 million for the same period last year.

• Consolidated operating income increased 8.2%, or $7.7 million, to $101.7 million for the six months ended August 31, 2019, compared to $94.0 million for the same period last year. Consolidated operating margin increased 0.3 percentage points to 12.9% of consolidated net sales revenue for the six months ended August 31, 2019, compared to 12.6% for the same period last year. The six months ended August 31, 2019 included pre-tax restructuring charges of $1.0 million compared to pre-tax restructuring charges of $2.6 million for the same period last year.

• Consolidated adjusted operating income increased 8.7%, or $10.0 million, to $125.1 million for the six months ended August 31, 2019, compared to $115.1 million for the same period last year. Consolidated adjusted operating margin increased 0.4 percentage points to 15.8% of consolidated net sales revenue for the six months ended August 31, 2019, compared to 15.4% for the same period last year.

• Income from continuing operations increased 5.6%, or $4.6 million, to $86.8 million for the six months ended August 31, 2019, compared to $82.2 million for the same period last year. Diluted

29

EPS from continuing operations increased 11.3% to $3.44 for the six months ended August 31, 2019, compared to $3.09 for the same period last year.

• Adjusted income from continuing operations increased 6.2%, or $6.3 million, to $108.6 million for the six months ended August 31, 2019, compared to $102.3 million for the same period last year. Adjusted diluted EPS from continuing operations increased 11.7% to $4.30 for the six months ended August 31, 2019, compared to $3.85 for the same period last year.

• There were no results from discontinued operations for the six months ended August 31, 2019, compared to a loss of $0.4 million, or $0.01 per share, for the same period last year.

• Net income increased 6.1%, or $5.0 million, to $86.8 million for the six months ended August 31, 2019 compared to $81.8 million for the same period last year. Diluted EPS increased 12.1% to $3.44 for the six months ended August 31, 2019 compared to $3.07 for the same period last year.

Consolidated and Segment Net Sales

The following tables summarize the impact that core business, foreign exchange and acquisitions, as applicable, had on our net sales revenue by segment: 

	Three Months Ended August 31,
(in thousands)	Housewares			Health & Home			Beauty			Total
Fiscal 2019 sales revenue, net	$	137,498		$	175,783		$	80,267		$	393,548
Core business growth (decline)	30,837			(15,943		)	7,494			22,388
Impact of foreign currency	(471		)	(1,050		)	(420		)	(1,941		)
Change in sales revenue, net	30,366			(16,993		)	7,074			20,447
Fiscal 2020 sales revenue, net	$	167,864		$	158,790		$	87,341		$	413,995
Total net sales revenue growth (decline)	22.1		%	(9.7		)%	8.8		%	5.2		%
Core business growth (decline)	22.4		%	(9.1		)%	9.3		%	5.7		%
Impact of foreign currency	(0.3		)%	(0.6		)%	(0.5		)%	(0.5		)%

	Six Months Ended August 31,
(in thousands)	Housewares			Health & Home			Beauty			Total
Fiscal 2019 sales revenue, net	$	254,801		$	339,214		$	154,212		$	748,227
Core business growth (decline)	58,767			(22,536		)	10,334			46,565
Impact of foreign currency	(762		)	(2,945		)	(755		)	(4,462		)
Change in sales revenue, net	58,005			(25,481		)	9,579			42,103
Fiscal 2020 sales revenue, net	$	312,806		$	313,733		$	163,791		$	790,330
Total net sales revenue growth (decline)	22.8		%	(7.5		)%	6.2		%	5.6		%
Core business growth (decline)	23.1		%	(6.6		)%	6.7		%	6.2		%
Impact of foreign currency	(0.3		)%	(0.9		)%	(0.5		)%	(0.6		)%

In the above tables, core business refers to our net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand is acquired, excluding the impact that foreign currency had on reported net sales. Net sales revenue from internally developed brands or product lines is considered core business activity.

30

Leadership Brand and Other Net Sales

The following tables summarize our Leadership Brand and other net sales:

	Three Months Ended August 31,
(in thousands)	2019		2018		$ Change		% Change
Leadership Brand sales revenue, net	$	331,183	$	319,045	$	12,138	3.8	%
All other sales revenue, net	82,812		74,503		8,309		11.2	%
Total sales revenue, net	$	413,995	$	393,548	$	20,447	5.2	%

	Six Months Ended August 31,
(in thousands)	2019		2018		$ Change		% Change
Leadership Brand sales revenue, net	$	632,742	$	599,804	$	32,938	5.5	%
All other sales revenue, net	157,588		148,423		9,165		6.2	%
Total sales revenue, net	$	790,330	$	748,227	$	42,103	5.6	%

Consolidated Net Sales Revenue

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Consolidated net sales revenue increased $20.4 million, or 5.2%, to $414.0 million for the three months ended August 31, 2019, compared to $393.5 million for the same period last year.  The growth was driven by a core business increase of $22.4 million, or 5.7%, primarily reflecting:

• an increase in brick and mortar sales in our Housewares segment;

• growth in consolidated online sales; and

• an increase in sales in the appliance category in the Beauty segment.

These factors were partially offset by:

• lower sales in our Health & Home segment;

• the unfavorable impact from foreign currency fluctuations of approximately $1.9 million, or 0.5%; and

• a decline in the personal care category within the Beauty segment.

Net sales from our Leadership Brands were $331.2 million for the three months ended August 31, 2019, compared to $319.0 million for the same period last year, representing growth of 3.8%.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Consolidated net sales revenue increased $42.1 million, or 5.6%, to $790.3 million for the six months ended August 31, 2019, compared to $748.2 million for the same period last year. The growth was driven by a core business increase of $46.6 million, or 6.2%, primarily reflecting:

• an increase in brick and mortar sales in our Housewares segment;

• growth in consolidated online sales; and

• an increase in sales in the appliance category in the Beauty segment.

These factors were partially offset by:

• lower domestic sales in our Health & Home segment;

• a decline in consolidated international sales;

• a decline in the personal care category within the Beauty segment; and

• the unfavorable impact from net foreign currency fluctuations of approximately $4.5 million, or 0.6%.

Net sales from our Leadership Brands were $632.7 million for the six months ended August 31, 2019, compared to $599.8 million for the same period last year, representing growth of 5.5%.

31

Segment Net Sales Revenue 

Housewares

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Net sales revenue in the Housewares segment increased $30.4 million, or 22.1%, to $167.9 million for the three months ended August 31, 2019, compared to $137.5 million for the same period last year. Growth was driven by a core business increase of $30.8 million, or 22.4%, primarily due to:

• point of sale growth and incremental distribution with existing domestic brick and mortar customers;

• an increase in online sales;

• an increase in international sales; and

• new product introductions.

These factors were partially offset by the unfavorable impact of net foreign currency fluctuations of approximately $0.5 million, or 0.3%.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Net sales revenue in the Housewares segment increased $58.0 million, or 22.8%, to $312.8 million for the six months ended August 31, 2019, compared to $254.8 million for same period last year. Growth was primarily driven by a core business increase of $58.8 million, or 23.1%, due to:

• point of sale growth and incremental distribution with existing domestic brick and mortar customers;

• an increase in online sales; and

• new product introductions.

These factors were partially offset by the unfavorable impact of net foreign currency fluctuations of approximately $0.8 million, or 0.3%.

Health & Home

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Net sales revenue in the Health & Home segment decreased $17.0 million, or 9.7%, to $158.8 million for the three months ended August 31, 2019, compared to $175.8 million for the same period last year. The decline was primarily driven by a core business decline of $15.9 million, or 9.1% due to:

• lower domestic sales driven by the unfavorable comparative impact from the timing of seasonal shipments, less wildfire activity, and net distribution changes year-over-year; and

• lower international sales.

These factors were partially offset by revenue from new product introductions.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Net sales revenue in the Health & Home segment decreased $25.5 million, or 7.5%, to $313.7 million for the six months ended August 31, 2019, compared to $339.2 million for the same period last year. The decline was primarily driven by a core business decline of $22.5 million, or 6.6%, due to:

• lower domestic sales driven by the unfavorable comparative impacts of a strong cough/cold/flu season, less wildfire activity and net distribution changes year-over-year; and

• lower international sales.

These factors were partially offset by revenue from new product introductions.

32

Beauty

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Net sales revenue in the Beauty segment increased $7.1 million, or 8.8%, to $87.3 million for the three months ended August 31, 2019, compared to $80.3 million for the same period last year. The increase was driven by an increase in core business sales of $7.5 million, or 9.3%, primarily due to:

• increased demand and new product introductions in the appliance category;

• growth in the online channel; and

• an increase in international sales.

These factors were partially offset by a decrease in brick and mortar sales, a decline in the personal care category and the unfavorable impact of net foreign currency fluctuations of approximately $0.4 million, or 0.5%.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Net sales revenue in the Beauty segment increased $9.6 million, or 6.2%, to $163.8 million for the six months ended August 31, 2019, compared to $154.2 million for the same period last year. The growth was driven by a core business increase of $10.3 million, or 6.7%, primarily due to:

• increased sales from new product introductions in the appliance category;

• growth in the online channel; and

• an increase in international sales.

These factors were partially offset by a decline in brick and mortar sales, a decrease in the personal care category and the unfavorable impact of net foreign currency fluctuations of approximately $0.8 million, or 0.5%.

Consolidated Gross Profit Margin

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Consolidated gross profit margin for the three months ended August 31, 2019 increased 3.6 percentage points to 43.0%, compared to 39.4% for the same period last year. The increase in consolidated gross profit margin is primarily due to:

• a higher mix of Housewares revenue at a higher overall gross profit margin;

• tariff exclusion refunds received for certain duties expensed in the second half of fiscal 2019 and the first quarter of 2020; and

• a lower mix of shipments made on a direct import basis.

These factors were partially offset by the net margin dilutive impact from tariffs and related pricing actions, unfavorable foreign currency fluctuations, a lower mix of personal care sales and higher inbound freight expense.

33

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Consolidated gross profit margin for the six months ended August 31, 2019 increased 1.7 percentage points to 42.0%, compared to 40.3% for the same period last year. The increase in consolidated gross profit margin is primarily due to:

• a higher mix of Housewares sales at a higher overall gross profit margin;

• tariff exclusion refunds received for certain duties expensed in the second half of fiscal 2019 and the first quarter of fiscal 2020; and

• a lower mix of shipments made on a direct import basis.

These factors were partially offset by the net margin dilutive impact from tariffs and related pricing actions, a lower mix of personal care sales, unfavorable foreign currency fluctuations and higher inbound freight expense.

Consolidated SG&A

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Consolidated SG&A ratio increased 3.5 percentage points to 29.8% for the three months ended August 31, 2019, compared to 26.3% for the same period last year. The increase in the consolidated SG&A ratio is primarily due to:

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• the unfavorable impact of a lower mix of shipments made on a direct import basis;

• higher outbound freight expense;

•higher advertising and new product development expense; and

•higher amortization expense.

These factors were partially offset by the impact from tariff related pricing actions taken with retail customers, the impact that higher overall sales had on net operating leverage, and the favorable impact from foreign currency exchange and forward contract settlements.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Consolidated SG&A ratio increased 1.6 percentage points to 29.0% for the six months ended August 31, 2019, compared to 27.4% for the same period last year. The increase in the consolidated SG&A ratio was primarily due to:

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• the unfavorable impact of a lower mix of shipments made on a direct import basis;

• higher outbound freight expense;

•higher advertising and new product development expense; and

•higher amortization expense.

These factors were partially offset by:

•the impact from tariff related pricing actions taken with retail customers;

•the impact that higher overall sales had on net operating leverage; and

•the favorable impact of foreign currency exchange and forward contract settlements.

Restructuring Charges

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

During the three months ended August 31, 2019, we incurred $0.4 million of pre-tax restructuring charges compared to $0.9 million for the same period last year. The charges related primarily to employee severance and termination benefits and contract termination costs.

34

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

During the six months ended August 31, 2019, we incurred $1.0 million of pre-tax restructuring charges compared to $2.6 million of pre-tax restructuring charges during the same period last year. The charges related primarily to employee severance and termination benefits and contract termination costs.

35

Operating income, operating margin, adjusted operating income (non-GAAP), and adjusted operating margin (non-GAAP) by segment

In order to provide a better understanding of the comparative impact of certain items on operating income, the tables that follow report the comparative before tax impact of restructuring charges, amortization of intangible assets, and non‐cash share‐based compensation, as applicable, on operating income and operating margin for each segment and in total for the periods covered below.  Adjusted operating income and adjusted operating margin may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100.  For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

	Three Months Ended August 31, 2019
(In thousands)	Housewares				Health & Home				Beauty				Total
Operating income, as reported (GAAP)	$	35,698	21.3	%	$	12,408	7.8	%	$	6,414	7.3	%	$	54,520	13.2	%
Restructuring charges	2		—	%	—		—	%	428		0.5	%	430		0.1	%
Subtotal	35,700		21.3	%	12,408		7.8	%	6,842		7.8	%	54,950		13.3	%
Amortization of intangible assets	179		0.1	%	2,798		1.8	%	1,486		1.7	%	4,463		1.1	%
Non-cash share-based compensation	1,769		1.1	%	2,519		1.6	%	2,093		2.4	%	6,381		1.5	%
Adjusted operating income (non-GAAP)	37,648		22.4	%	17,725		11.2	%	10,421		11.9	%	65,794		15.9	%

	Three Months Ended August 31, 2018
(In thousands)	Housewares				Health & Home				Beauty				Total
Operating income, as reported (GAAP)	$	28,329	20.6	%	$	13,631	7.8	%	$	8,700	10.8	%	$	50,660	12.9	%
Restructuring charges	—		—	%	—		—	%	859		1.1	%	859		0.2	%
Subtotal	28,329		20.6	%	13,631		7.8	%	9,559		11.9	%	51,519		13.1	%
Amortization of intangible assets	511		0.4	%	2,704		1.5	%	186		0.2	%	3,401		0.9	%
Non-cash share-based compensation	1,994		1.5	%	2,156		1.2	%	539		0.7	%	4,689		1.2	%
Adjusted operating income (non-GAAP)	30,834		22.4	%	18,491		10.5	%	10,284		12.8	%	59,609		15.1	%

	Six Months Ended August 31, 2019
(In thousands)	Housewares				Health & Home				Beauty				Total
Operating income, as reported (GAAP)	$	66,898	21.4	%	$	27,464	8.8	%	$	7,365	4.5	%	$	101,727	12.9	%
Restructuring charges	90		—	%	—		—	%	959		0.6	%	1,049		0.1	%
Subtotal	66,988		21.4	%	27,464		8.8	%	8,324		5.1	%	102,776		13.0	%
Amortization of intangible assets	697		0.2	%	5,596		1.8	%	2,046		1.2	%	8,339		1.1	%
Non-cash share-based compensation	4,343		1.4	%	5,893		1.9	%	3,749		2.3	%	13,985		1.8	%
Adjusted operating income (non-GAAP)	$	72,028	23.0	%	$	38,953	12.4	%	$	14,119	8.6	%	$	125,100	15.8	%

	Six Months Ended August 31, 2018
(In thousands)	Housewares				Health & Home				Beauty				Total
Operating income, as reported (GAAP)	$	50,512	19.8	%	$	33,288	9.8	%	$	10,187	6.6	%	$	93,987	12.6	%
Restructuring charges	760		0.3	%	358		0.1	%	1,466		1.0	%	2,584		0.3	%
Subtotal	51,272		20.1	%	33,646		9.9	%	11,653		7.6	%	96,571		12.9	%
Amortization of intangible assets	985		0.4	%	5,408		1.6	%	1,129		0.7	%	7,522		1.0	%
Non-cash share-based compensation	3,980		1.6	%	4,482		1.3	%	2,551		1.7	%	11,013		1.5	%
Adjusted operating income (non-GAAP)	$	56,237	22.1	%	$	43,536	12.8	%	$	15,333	9.9	%	$	115,106	15.4	%

36

Consolidated Operating Income

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Consolidated operating income was $54.5 million, or 13.2% of net sales, compared to $50.7 million, or 12.9% of net sales, for the same period last year.  The increase was driven by the following factors:

• tariff exclusion refunds received for certain duties expensed in the second half of fiscal 2019 and the first quarter of fiscal 2020;

• a higher mix of Housewares sales at a higher overall operating margin;

• the impact of favorable foreign currency exchange contracts and remeasurement on SG&A;

• the favorable impact that higher overall net sales had on operating expense leverage; and

• the net favorable comparative impact of pre-tax restructuring charges of $0.4 million.

These factors were partially offset by:

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• higher advertising and new product development expense;

• higher amortization expense;

• higher freight and distribution expense; and

• the impact of unfavorable foreign currency fluctuations on net sales and operating margin.

Consolidated adjusted operating income increased 10.4% to $65.8 million, or 15.9% of net sales, compared to $59.6 million, or 15.1% of net sales, in the same period last year. 

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Consolidated operating income was $101.7 million, or 12.9% of net sales, compared to $94.0 million, or 12.6% of net sales, for the same period last year.  The increase was driven by the following factors:

• tariff exclusion refunds received for certain duties expensed in the second half of fiscal 2019 and the first quarter of fiscal 2020;

• a higher mix of Housewares sales at a higher overall operating margin;

• the impact of favorable foreign currency exchange contracts and remeasurement on SG&A;

• the favorable impact that higher overall net sales had on operating expense leverage; and

• the net favorable comparative impact of pre-tax restructuring charges of $1.5 million.

These factors were partially offset by:

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• higher advertising and new product development expense;

• higher amortization expense;

• higher freight and distribution expense; and

• the impact of unfavorable foreign currency fluctuations on net sales and operating margin.

Consolidated adjusted operating income increased 8.7% to $125.1 million, or 15.8% of net sales, compared to $115.1 million, or 15.4% of net sales, for the same period last year. 

37

Housewares

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Housewares operating income was $35.7 million, or 21.3% of segment net sales, compared to $28.3 million, or 20.6% of segment net sales, for the same period last year. The 0.7 percentage point increase in segment operating margin is primarily due to:

• the margin impact of a more favorable product and channel mix; and

• the impact that higher sales had on operating leverage.

These factors were partially offset by:

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• higher new product development expense; and

• higher freight and distribution center expense to support increased volume and integration activity.

Adjusted operating income increased 22.1% to $37.6 million, or 22.4% of segment net sales, compared to $30.8 million, or 22.4% of segment net sales, in the same period last year.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Housewares operating income was $66.9 million, or 21.4% of segment net sales, for the six months ended August 31, 2019, compared to $50.5 million, or 19.8% of segment net sales, in the same period last year. The 1.6 percentage point increase in segment operating margin is primarily due to:

• the margin impact of a more favorable product and channel mix;

• the impact that higher sales had on operating leverage; and

• the net favorable comparative impact of pre-tax restructuring charges of $0.7 million.

These factors were partially offset by:

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• higher advertising and new product development expense; and

• higher freight and distribution center expense to support increased volume and integration activity.

Adjusted operating income increased 28.1% to $72.0 million, or 23.0% of segment net sales, compared to $56.2 million, or 22.1% of segment net sales, in the same period last year.

Health & Home

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Health & Home operating income was $12.4 million, or 7.8% of segment net sales, compared to $13.6 million, or 7.8% of segment net sales in the same period last year. Segment operating margin was flat compared to the prior year period primarily due to the following unfavorable impacts:

• higher media advertising expense;

• unfavorable operating leverage from the decline in sales;

• higher share-based compensation expense;

• the margin impact of a less favorable channel mix; and

• the impact of unfavorable foreign currency exchange fluctuations on net sales and operating margin.

These factors were offset by tariff exclusion refunds received for certain duties expensed in the second half of fiscal 2019 and the first quarter of fiscal 2020 and the impact of favorable foreign currency exchange contracts and remeasurement on SG&A.

38

Adjusted operating income decreased 4.1% to $17.7 million, or 11.2% of segment net sales, compared to $18.5 million, or 10.5% of segment net sales, in the same period last year.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Health & Home operating income was $27.5 million, or 8.8% of segment net sales, compared to $33.3 million, or 9.8% of segment net sales, in the same period last year. The 1.0 percentage point decrease in segment operating margin is primarily due to:

• the impact of unfavorable foreign currency fluctuations on net sales and operating margin;

• higher media advertising expense;

• unfavorable operating leverage from the decline in sales; and

• the margin impact of a less favorable channel mix.

These factors were partially offset by tariff exclusion refunds received for certain duties expensed in the second half of fiscal 2019 and first quarter of fiscal 2020, lower product claim liability expense and the impact of favorable foreign currency contracts and remeasurement on SG&A.

Adjusted operating income decreased 10.5% to $39.0 million, or 12.4% of segment net sales, compared to $43.5 million, or 12.8% of segment net sales, in the same period last year.

Beauty

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Beauty operating income was $6.4 million, or 7.3% of segment net sales, compared to $8.7 million, or 10.8% of segment net sales, in the same period last year. The 3.5 percentage point decrease in segment operating margin is primarily due to:

• the impact of higher freight expense to meet strong demand in the appliance category;

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• higher amortization expense;

• the margin impact of a less favorable product and channel mix; and

• the impact of unfavorable foreign currency fluctuations on net sales and operating margin.

These factors were partially offset by lower advertising expense and the net favorable comparative impact of pre-tax restructuring charges of $0.4 million.

Adjusted operating income increased 1.3% to $10.4 million, or 11.9% of segment net sales, compared to $10.3 million, or 12.8% of segment net sales, in the same period last year.

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Beauty operating income was $7.4 million, or 4.5% of segment net sales, compared to operating income of $10.2 million, or 6.6% of segment net sales, in the same period last year. The 2.1 percentage point decrease in segment operating margin is primarily due to:

• the impact of higher freight expense to meet strong demand in the appliance category;

• higher annual incentive and share-based compensation expense related to short- and long-term performance;

• the impact of unfavorable foreign currency fluctuations on net sales and operating margin;

• higher amortization expense; and

• the margin impact of a less favorable product and channel mix.

These factors were partially offset by lower advertising expense and the net favorable comparative impact of pre-tax restructuring charges of $0.5 million.

39

Adjusted operating income decreased 7.9% to $14.1 million, or 8.6% of segment net sales, compared to $15.3 million, or 9.9% of segment net sales, in the same period last year.

Interest Expense

Interest expense was $3.2 million for the three months ended August 31, 2019, compared to $2.8 million in the same period last year. Interest expense was $6.5 million for the six months ended August 31, 2019 compared to $5.4 million in the same period last year. The increase in interest expense was primarily due to higher average levels of debt outstanding and higher average interest rates compared to the same periods last year.

Income Tax Expense

The period-over-period comparison of our effective tax rate is impacted by the mix of taxable income in our various tax jurisdictions. Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate.

For the three months ended August 31, 2019, income tax expense as a percentage of income before income tax was 10.3% compared to 8.3% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates.

For the six months ended August 31, 2019, income tax expense as a percentage of income before income tax was 9.0%, which included $0.8 million of tax benefits from share-based compensation settlements, $1.7 million of expense from the remeasurement of deferred taxes due to tax rate changes, and a $2.8 million benefit from the resolution of an uncertain tax position. Income tax expense as a percentage of income before income tax was 7.3% for the same period last year, which included $0.5 million tax benefits from share-based compensation settlements and a $0.8 million benefit from the lapse of the statute of limitations related to an uncertain tax position. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates.

During fiscal 2017, we received an assessment from a state tax authority which adjusted taxable income applicable to the particular state resulting from interpretations of certain state income tax provisions applicable to our legal structure.  We believe we have accurately reported our taxable income and are vigorously protesting the assessment through administrative processes with the state.  We believe it is unlikely that the outcome of these matters will have a material adverse effect on our consolidated financial position, results of operations, or liquidity.

Our Macau subsidiary generates income from the sale of the goods it has sourced and procured. This subsidiary is responsible for the sourcing and procurement of a large portion of the products that we sell. We currently have an indefinite tax holiday in Macau conditioned on the subsidiary meeting certain employment and investment thresholds. The Macau Offshore Law and its supplementary regulations that grant tax incentives to approved offshore institutions will be abolished on January 1, 2021. Existing approved offshore institutions such as ours can continue to operate under the offshore regime until the end of the calendar year 2020. Beginning in calendar year 2021, we believe our Macau subsidiary will become subject to a statutory corporate income tax of approximately 12%. The ultimate impact of this change, if any, on our overall effective tax rate will depend on a variety of factors including our mix of income by jurisdiction, transfer pricing considerations and the specific tax regulations applicable to us when we are no longer under the Macau Offshore regime. It is not practicable for us to determine the potential impact on our financial statements until the tax changes in Macau are fully established and our

40

transfer pricing analysis is complete. Because our Macau subsidiary is not directly or indirectly owned by a U.S. parent, there is no U.S. tax liability associated with the income generated in Macau.

41

Income from continuing operations, diluted EPS from continuing operations, adjusted income from continuing operations (non-GAAP), and adjusted diluted EPS from continuing operations (non-GAAP)

In order to provide a better understanding of the impact of certain items on our income and EPS from continuing operations, the analysis that follows reports the comparative after tax impact of restructuring charges, amortization of intangible assets, and non-cash share‐based compensation, as applicable, on income from continuing operations, and diluted EPS from continuing operations for the periods covered below. For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

	Three Months Ended August 31, 2019
	Income From Continuing Operations						Diluted EPS From Continuing Operations
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	51,393	$	5,298	$	46,095	$	2.04	$	0.21	$	1.83
Restructuring charges	430		66		364		0.02		—		0.01
Subtotal	51,823		5,364		46,459		2.05		0.21		1.84
Amortization of intangible assets	4,463		248		4,215		0.18		0.01		0.17
Non-cash share-based compensation	6,381		515		5,866		0.25		0.02		0.23
Adjusted (non-GAAP)	$	62,667	$	6,127	$	56,540	$	2.48	$	0.24	$	2.24
Weighted average shares of common stock used in computing diluted EPS											25,245

	Three Months Ended August 31, 2018
	Income From Continuing Operations						Diluted EPS From Continuing Operations
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	47,990	$	3,973	$	44,017	$	1.81	$	0.15	$	1.66
Restructuring charges	859		41		818		0.03		—		0.03
Subtotal	48,849		4,014		44,835		1.84		0.15		1.69
Amortization of intangible assets	3,402		56		3,346		0.13		—		0.13
Non-cash share-based compensation	4,689		337		4,352		0.18		0.01		0.16
Adjusted (non-GAAP)	$	56,940	$	4,407	$	52,533	$	2.14	$	0.17	$	1.98
Weighted average shares of common stock used in computing diluted EPS											26,557

42

	Six Months Ended August 31, 2019
	Income From Continuing Operations						Diluted EPS From Continuing Operations
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	95,424	$	8,635	$	86,789	$	3.78	$	0.34	$	3.44
Restructuring charges	1,049		68		981		0.04		—		0.04
Subtotal	96,473		8,703		87,770		3.82		0.34		3.48
Amortization of intangible assets	8,339		369		7,970		0.33		0.01		0.32
Non-cash share-based compensation	13,985		1,091		12,894		0.55		0.04		0.51
Adjusted (non-GAAP)	$	118,797	$	10,163	$	108,634	$	4.71	$	0.40	$	4.30
Weighted average shares of common stock used in computing diluted EPS											25,245

	Six Months Ended August 31, 2018
	Income From Continuing Operations						Diluted EPS From Continuing Operations
(in thousands, except per share data)	Before Tax		Tax		Net of Tax		Before Tax		Tax		Net of Tax
As reported (GAAP)	$	88,705	$	6,515	$	82,190	$	3.33	$	0.24	$	3.09
Restructuring charges	2,584		183		2,401		0.10		0.01		0.09
Subtotal	91,289		6,698		84,591		3.43		0.25		3.18
Amortization of intangible assets	7,522		190		7,332		0.28		0.01		0.28
Non-cash share-based compensation	11,013		606		10,407		0.41		0.02		0.39
Adjusted (non-GAAP)	$	109,824	$	7,494	$	102,330	$	4.13	$	0.28	$	3.85
Weighted average shares of common stock used in computing diluted EPS											26,612

Comparison of Second Quarter Fiscal 2020 to Second Quarter Fiscal 2019

Income from continuing operations was $46.1 million for the three months ended August 31, 2019 compared to $44.0 million for the same period last year.  Diluted EPS from continuing operations was $1.83 for the three months ended August 31, 2019 compared to $1.66 for the same period last year. Diluted EPS increased primarily due to higher operating income from our Housewares segment and the impact of lower weighted average diluted shares outstanding compared to the same period last year. This was partially offset by lower operating income from our Health & Home and Beauty segments, higher interest expense and higher income tax expense.

Adjusted income from continuing operations increased $4.0 million, or 7.6%, to $56.5 million for the three months ended August 31, 2019 compared to $52.5 million the same period last year.  Adjusted diluted EPS from continuing operations increased 13.1% to $2.24 for the three months ended August 31, 2019 compared to $1.98 for the same period last year.  

Comparison of First Six Months of Fiscal 2020 to First Six Months of Fiscal 2019

Income from continuing operations was $86.8 million for the six months ended August 31, 2019 compared to $82.2 million for the same period last year.  Diluted EPS from continuing operations was $3.44 for the six months ended August 31, 2019 compared to $3.09 for the same period last year. Diluted EPS increased primarily due to the impact of higher operating income in our Housewares segment and lower weighted average diluted shares outstanding compared to the same period last year. This was partially offset by lower operating income from our Health & Home and Beauty segments, higher interest expense and higher income tax expense.

Adjusted income from continuing operations increased $6.3 million, or 6.2%, to $108.6 million for the six months ended August 31, 2019 compared to $102.3 million the same period last year.  Adjusted diluted EPS from continuing operations increased 11.7% to $4.30 for the six months ended August 31, 2019 compared to $3.85 for the same period last year.  

43

Financial Condition, Liquidity and Capital Resources

Selected measures of our liquidity and capital resources are shown for the periods below :  

	Six Months Ended August 31,
	2019			2018
Accounts Receivable Turnover (Days) (1)	68.4			65.4
Inventory Turnover (Times) (1)	2.9			3.3
Working Capital (in thousands)	$	393,514		$	338,360
Current Ratio	2.2:1			2.1:1
Ending Debt to Ending Equity Ratio	27.7		%	28.0		%
Return on Average Equity (1)	17.1		%	14.5		%

_____________________

(1) Accounts receivable turnover, inventory turnover and return on average equity computations use 12 month trailing net sales revenue, cost of goods sold or net income components as required by the particular measure. The current and four prior quarters' ending balances of accounts receivable, inventory and equity are used for the purposes of computing the average balance component as required by the particular measure.

We rely principally on cash flows from operations and borrowings under our credit facility to finance our operations, acquisitions, and capital expenditures.  We believe our cash flows from operations and availability under our credit facility are sufficient to meet our working capital and capital expenditure needs. 

Operating Activities

Operating activities from continuing operations provided net cash of $38.2 million for the six months ended August 31, 2019 compared to $37.3 million for the same period last year.  The increase was primarily driven by an increase in income from continuing operations, higher non-cash expense, the collection of a $10.8 million supplemental payment during the second quarter of fiscal 2020 related to the divestiture of our former Nutritional Supplements segment, and the comparative impact of a $15.0 million dispute settlement payment made in the same period last year. These factors were offset by an increase in cash used for inventory, due in part to additional inventory to meet strong demand in retail appliances, as well as for risk management as we progress with supplier consolidation, complete and optimize a distribution center integration and support increased growth in volume.    

Investing Activities

During the six months ended August 31, 2019, we invested in capital and intangible asset expenditures of $8.9 million compared to $13.1 million for the same period last year.  

Financing Activities

Financing activities from continuing operations used $24.2 million of cash during the six months ended August 31, 2019, compared to $24.7 million for the same period last year.  A reduction in repurchases of common stock was offset by higher net repayments on our line of credit for the first six months of fiscal 2020 compared to the same period last year.

44

Credit and Other Debt Agreements

Credit Agreement

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.0 billion as of August 31, 2019. The commitment under the Credit Agreement terminates on December 7, 2021. Borrowings accrue interest under one of two alternative methods (based on a base rate or LIBOR) as described in the Credit Agreement. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time. We also incur loan commitment and letter of credit fees under the Credit Agreement. Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis. As of August 31, 2019, the outstanding revolving loan principal balance was $283.0 million (excluding prepaid financing fees) and the balance of outstanding letters of credit was $9.0 million. As of August 31, 2019, the amount available for borrowings under the Credit Agreement was $708.0 million. Covenants in our debt agreements limit the amount of total indebtedness we can incur.  As of August 31, 2019, these covenants effectively limited our ability to incur more than $609.0 million of additional debt from all sources, including our Credit Agreement, or $708.0 million in the event a qualified acquisition is consummated. 

Other Debt Agreements

We have an aggregate principal balance of $20.5 million (excluding prepaid financing fees) under a loan agreement with the Mississippi Business Finance Corporation (the “MBFC Loan”) as of August 31, 2019. The borrowings were used to fund construction of our Olive Branch, Mississippi distribution facility. The remaining loan balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and 14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023.

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain key financial covenants, defined in the table below. Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting us, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on our properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends. Our debt agreements also contain customary events of default, including failure to pay principal or interest when due, among others. Our debt agreements are cross-defaulted to each other. Upon an event of default under our debt agreements, the holders or lenders may, among other things, accelerate the maturity of any amounts outstanding under our debt agreements. The commitments of the lenders to make loans to us under the Credit Agreement are several and not joint. Accordingly, if any lender fails to make loans to us, our available liquidity could be reduced by an amount up to the aggregate amount of such lender’s commitments under the Credit Agreement.

The table below provides the formulas currently in effect for certain key financial covenants as defined under our debt agreements:

Applicable Financial Covenant	Credit Agreement and MBFC Loan
Interest Coverage Ratio	EBIT (1) ÷ Interest Expense (1)
	Minimum Required:  3.00 to 1.00
	Total Current and Long Term Debt (2) ÷
Maximum Leverage Ratio	EBITDA (1) + Pro Forma Effect of Acquisitions
	Maximum Currently Allowed:  3.50 to 1.00 (3)

45

Key Definitions:

EBIT:                 Earnings Before Non-Cash Charges, Interest Expense and Taxes

EBITDA:                EBIT + Depreciation and Amortization Expense + Share-based Compensation

Pro Forma Effect of Acquisitions:    For any acquisition, pre-acquisition EBITDA of the acquired business is included so that the

EBITDA of the acquired business included in the computation equals its twelve month trailing total.

Notes:

(1) Computed using totals for the latest reported four consecutive fiscal quarters.  

(2) Computed using the ending balances as of the latest reported fiscal quarter. 

(3) In the event a qualified acquisition is consummated, the maximum leverage ratio is 4.25 to 1.00. 

Contractual Obligations

There have been no material changes from the information provided in our latest annual report on Form 10-K.  Additional information regarding contractual obligations can be found in Notes 11 and 12 to the accompanying condensed consolidated financial statements.

Off-Balance Sheet Arrangements

We have no existing activities involving special purpose entities or off-balance sheet financing.

Current and Future Capital Needs

Based on our current financial condition and current operations, we believe that cash flows from operations and available financing sources will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements. We expect our capital needs to stem primarily from the need to purchase sufficient levels of inventory and to carry normal levels of accounts receivable on our balance sheet. In addition, we continue to evaluate acquisition opportunities on a regular basis. We may finance acquisition activity with available cash, the issuance of shares of common stock, additional debt, or other sources of financing, depending upon the size and nature of any such transaction and the status of the capital markets at the time of such acquisition. We may also elect to repurchase additional shares of common stock under our Board authorization, subject to limitations contained in our debt agreements and based upon our assessment of a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. We may finance share repurchases with available cash, additional debt or other sources of financing. For additional information, see Part II, Item 5., “Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities” in our latest annual report on form 10-K and Part II, Item 2. "Unregistered Sales of Equity Securities and Use of Proceeds" in this report. As of August 31, 2019, the amount of cash and cash equivalents held by our foreign subsidiaries was $19.3 million, of which, an immaterial amount was held in foreign countries where the funds may not be readily convertible into other currencies.   

New Accounting Guidance

For information on recently adopted and issued accounting pronouncements, see Note 2 to the accompanying condensed consolidated financial statements.

46

Information Regarding Forward-Looking Statements

Certain written and oral statements may constitute "forward-looking statements" as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this report, in other filings with the Securities and Exchange Commission (the "SEC"), in press releases, and in certain other oral and written presentations. Generally, the words "anticipates", "believes", "expects", "plans", "may", "will", "should", "seeks", "estimates", "project", "predict", "potential", "continue", "intends", and other similar words identify forward-looking statements. All statements that address operating results, events or developments that may occur in the future, including statements related to sales, earnings per share results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions.  We believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct.  Forward-looking statements are subject to risks that could cause them to differ materially from actual results.  Accordingly, we caution readers not to place undue reliance on forward-looking statements.  We believe that these risks include but are not limited to the risks described in this report and that are otherwise described from time to time in our SEC reports as filed. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.

Such risks are not limited to, but may include:

• our ability to deliver products to our customers in a timely manner and according to their fulfillment standards;

• the costs of complying with the business demands and requirements of large sophisticated customers;

• our relationships with key customers and licensors;

• our dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn;

• our dependence on sales to several large customers and the risks associated with any loss or substantial decline in sales to top customers;

• expectations regarding Project Refuel and any other proposed restructuring;

• expectations regarding recent and future acquisitions or divestitures, including our ability to realize anticipated cost savings, synergies and other benefits along with our ability to effectively integrate acquired businesses or separate divested businesses;

• circumstances which may contribute to future impairment of goodwill, intangible or other long-lived assets;

• the retention and recruitment of key personnel;

• foreign currency exchange rate fluctuations;

• risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors;

• our dependence on foreign sources of supply and foreign manufacturing, and associated operational risks including, but not limited to, long lead times, consistent local labor availability and capacity, and timely availability of sufficient shipping carrier capacity;

• the impact of changing costs of raw materials, labor and energy on cost of goods sold and certain operating expenses;

• the risks associated with significant tariffs or other restrictions on imports from China or any retaliatory trade measures taken by China;

• the geographic concentration and peak season capacity of certain U.S. distribution facilities increases our exposure to significant shipping disruptions and added shipping and storage costs;

• our projections of product demand, sales and net income are highly subjective in nature and future sales and net income could vary in a material amount from such projections;

• the risks associated with the use of trademarks licensed from and to third parties;

47

• our ability to develop and introduce a continuing stream of new products to meet changing consumer preferences;

• trade barriers, exchange controls, expropriations, and other risks associated with U.S. and foreign operations;

• the risks to our liquidity as a result of changes to capital market conditions and other constraints or events that impose constraints on our cash resources and ability to operate our business;

• the costs, complexity and challenges of upgrading and managing our global information systems;

• the risks associated with cybersecurity and information security breaches;

• the risks associated with global legal developments regarding privacy and data security could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business;

• the risks associated with product recalls, product liability, other claims, and related litigation against us;

• the risks associated with accounting for tax positions, tax audits and related disputes with taxing authorities;

• the risks of potential changes in laws in the U.S. or abroad, including tax laws, regulations or treaties, employment and health insurance laws and regulations, laws relating to environmental policy, personal data, financial regulation, transportation policy and infrastructure policy along with the costs and complexities of compliance with such laws; and

• our ability to continue to avoid classification as a controlled foreign corporation.  

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in the information provided in the section entitled “Quantitative and Qualitative Disclosures about Market Risk” in our Form 10-K.  Additional information regarding risk management activities can be found in Notes 12, 13 and 14 to the accompanying condensed consolidated financial statements.

48

ITEM 4. CONTROLS AND PROCEDURES

DISCLOSURE CONTROLS AND PROCEDURES

Our management, under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), maintains disclosure controls and procedures as defined in Rules 13a-15(e) under the Exchange Act that are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosures. Because of inherent limitations, disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of disclosure controls and procedures are met.

Our management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended August 31, 2019. Based upon that evaluation, the CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable level of assurance as of August 31, 2019, the end of the period covered by this quarterly report on Form 10-Q.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

In connection with the evaluation described above, we identified no change in our internal control over financial reporting as defined in Rule 13a-15(f) of the Exchange Act that occurred during our fiscal quarter ended August 31, 2019, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS 

We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.  

ITEM 1A. RISK FACTORS  

The ownership of our common stock involves a number of risks and uncertainties. When evaluating the Company and our business before making an investment decision regarding our securities, potential investors should carefully consider the risk factors and uncertainties described in Part 1, Item 1A. “Risk Factors” of our annual report on Form 10-K for the fiscal year ended February 28, 2019.  Since the filing of our annual report on Form 10-K, there have been no material changes in our risk factors from those disclosed therein.

49

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS  

On May 8, 2019, our Board of Directors authorized the repurchase of up to $400 million of our outstanding common stock. The authorization is effective until May 2022 and replaced our former repurchase authorization, of which $107.4 million was outstanding at the time the new authorization was approved. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. See Note 9 to the accompanying condensed consolidated financial statements for additional information.

Our current equity-based compensation plans include provisions that allow for the "net exercise" of share settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares.

The following table summarizes our share repurchase activity for the periods shown:

Period	Total Number of Shares Purchased (1)(3)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (in thousands) (2)
June 1 to June 30, 2019	251	$	131.60	251	$	394,325
July 1 to July 31, 2019	1,970	142.11		1,970	394,045
August 1 to August 31, 2019	133	147.32		133	394,015
Total	2,354	$	145.96	2,354

(1) The number of shares above includes shares of common stock acquired from employees who tendered shares to: i) satisfy the tax withholding on equity awards as part of our long-term incentive plans or ii) satisfy the exercise price on stock option exercises. For the three months ended August 31, 2019, 2,354 shares were acquired at a weighted average per share price of $145.96.

(2) Reflects the remaining dollar value of shares that could be purchased under our current stock repurchase authorization through the expiration or termination of the plan. For additional information, see Note 9 to the accompanying condensed consolidated financial statements.

n

50

ITEM 6.	EXHIBITS
		(a)	Exhibits
			10.1+	Severance Agreement among Helen of Troy Nevada Corporation, a Nevada Corporation, Helen of Troy Limited, a Bermuda Company, and Brian L. Grass, effective June 17, 2019 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on June 21, 2019).
			31.1*	Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			31.2*	Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
			32**	Joint certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
			101	Financial statements from the Quarterly Report on Form 10-Q of the Company for the quarter ended August 31, 2019, formatted in Inline eXtensible Business Reporting Language ("iXBRL"): (i) Condensed Consolidated Balance Sheet, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders' Equity, (v) Condensed Consolidated Statements of Cash Flows and (vi) Notes to the Condensed Consolidated Financial Statements.
			104	Cover Page, formatted iXBRL and contained in Exhibit 101.
			*     Filed herewith.
			**   Furnished herewith.
			+ Management contracts or compensatory plans or arrangements

51

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

		HELEN OF TROY LIMITED
		(Registrant)
Date:	October 10, 2019	/s/ Julien R. Mininberg
		Julien R. Mininberg
		Chief Executive Officer,   Director and Principal Executive Officer
Date:	October 10, 2019	/s/ Brian L. Grass
		Brian L. Grass
		Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer

52

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Julien R. Mininberg, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended August 31, 2019 of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: October 10, 2019

/s/ Julien R. Mininberg

Julien R. Mininberg

Chief Executive Officer,

Director and Principal Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Brian L. Grass, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the fiscal quarter ended August 31, 2019 of Helen of Troy Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: October 10, 2019

/s/ Brian L. Grass

Brian L. Grass

Chief Financial Officer, Principal Financial

Officer and Principal Accounting Officer

EX-32

EXHIBIT 32

CERTIFICATION

In connection with the quarterly report of Helen of Troy Limited (the “Company”) on Form 10-Q for the fiscal quarter ended August 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, the Chief Executive Officer and Chief Financial Officer of the Company, hereby certifies that to the best of their knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: October 10, 2019

/s/ Julien R. Mininberg

Julien R. Mininberg

Chief Executive Officer,

Director and Principal Executive Officer

/s/ Brian L. Grass

Brian L. Grass

Chief Financial Officer, Principal Financial Officer

and Principal Accounting Officer

This certification is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification is not deemed to be incorporated by reference into any filing under the Securities Act of 1933 or Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.

XML

Financial Instruments and Risk Management - Interest Rate Risk (Details) - Credit agreement $ in Millions	Aug. 31, 2019 USD ($)
Financial instruments and risk management
Fixed rate debt	$ 225.0
Floating rate debt	$ 283.0

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Income Tax Disclosure [Abstract]
Income tax expense (benefit) as a percent of income before income taxes	10.30%	8.30%	9.00%	7.30%
Tax benefit recorded related to the recognition of excess tax benefits from share-based compensation			$ 0.8	$ 0.5
Expense for remeasurement of deferred taxes			1.7
Unrecognized tax benefit from favorable resolution of uncertain tax position			$ 2.8	$ 0.8

XML

Goodwill and Intangible Assets - Additional information (Details) - USD ($) $ in Thousands	Aug. 31, 2019	May 31, 2019	Feb. 28, 2019
Trademarks | Beauty
Finite-Lived Intangible Assets [Line Items]
Net book value transferred from indefinite lived to finite lived assets	$ 28,601	$ 30,400	$ 48

XML

Consolidated Condensed Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 46,095	$ 44,017	$ 86,789	$ 81,809
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps	(3,168)	101	(7,161)	205
Cash flow hedge activity - foreign currency contracts	424	478	1,215	3,811
Total other comprehensive income (loss), net of tax	(2,744)	579	(5,946)	4,016
Comprehensive income	$ 43,351	$ 44,596	$ 80,843	$ 85,825

XML

Cover page - shares	6 Months Ended
	Aug. 31, 2019	Oct. 04, 2019
Entity Addresses [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Aug. 31, 2019
Document Transition Report	false
Entity File Number	001-14669
Entity Registrant Name	HELEN OF TROY LIMITED
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	74-2692550
Entity Address, Address Line One	1 Helen of Troy Plaza
Entity Address, State or Province	El Paso
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	79912
City Area Code	915
Local Phone Number	225-8000
Title of 12(b) Security	Common Shares, $0.10 Par Value Per Share
Trading Symbol	HELE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		25,163,993
Entity Central Index Key	0000916789
Current Fiscal Year End Date	--02-28
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false
Other Address
Entity Addresses [Line Items]
Entity Address, Address Line One	Clarendon House, 2 Church Street
Entity Address, State or Province	Hamilton
Entity Address, State or Province	BM

XML

New Accounting Pronouncements

6 Months Ended

Aug. 31, 2019

Accounting Changes and Error Corrections [Abstract]

New Accounting Pronouncements

New Accounting Pronouncements

Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K for the fiscal year ended February 28, 2019.  

Adopted in Fiscal 2020

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The new guidance requires the recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and corresponding right-of-use assets on a balance sheet for most leases, along with requirements for enhanced disclosures to give financial statement users the ability to assess the amount, timing and uncertainty of cash flows arising from leasing arrangements. In July 2018, the FASB issued guidance which permits application of the new guidance at the beginning of the year of adoption, recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, in addition to the method of applying the new guidance retrospectively to each prior reporting period presented. We adopted the standard in the first quarter of fiscal 2020 using the transition method introduced by ASU 2018-11, which does not require revisions to comparative periods. We elected to implement the transition package of practical expedients permitted within the new standard, which included (i) not reassessing whether expired or existing contracts contain leases, (ii) not reassessing lease classification, and (iii) not revaluing initial direct costs for existing leases. Adoption of the new standard resulted in the recording of initial lease assets and lease liabilities of approximately $37.1 million and $47.2 million, respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to deferred rent and unamortized lease incentives recorded in accordance with the previous lease guidance. The new standard did not materially impact our condensed consolidated statements of income or cash flows (see Note 4).

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (Topic 815), which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. In April 2019, the FASB issued ASU 2019-04, which provides clarifications and minor improvements related to Topic 815. Adoption of this guidance in the first quarter of fiscal 2020 did not have a material impact on our consolidated financial statements.

XML

Discontinued Operation (Details) - Discontinued Operations - Healthy Directions LLC - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Aug. 31, 2019	Feb. 28, 2019	Feb. 28, 2018	Dec. 31, 2017
Discontinued Operations
Purchase price from sale				$ 46.0
Supplemental payment				$ 25.0
Final adjusted supplemental payment	$ 10.8		$ 10.8
Reduction of supplemental payment	5.8
Reduction of supplemental payment after tax	$ 4.4
Resolution of certain contingencies		$ 1.5
Resolution of certain contingencies after tax		$ 1.3

XML

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Aug. 31, 2019	Aug. 31, 2019	Mar. 01, 2019
Lessee, Lease, Description [Line Items]
Operating lease assets	$ 34,429	$ 34,429
Present value of lease liability	45,625	45,625	$ 47,223
Operating lease expense	$ 1,700	$ 3,300
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease assets			37,100
Present value of lease liability			$ 47,200
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease terms		1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease terms		14 years

XML

Fair Value

6 Months Ended

Aug. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value

Fair Value 

We classify our various assets and liabilities recorded or reported at fair value under a hierarchy prescribed by GAAP that prioritizes inputs to fair value measurement techniques into three broad levels:

Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets;

Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and

Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

Assets and liabilities subject to classification are classified upon acquisition.  When circumstances dictate the transfer of an asset or liability to a different level, our policy is to recognize the transfer at the beginning of the reporting period in which the event resulting in the transfer occurred.

The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown:

	Fair Values at
	August 31, 2019
(in thousands)	(Level 2) (1)
Assets:
Money market accounts	$	1,232
Interest rate swaps	—
Foreign currency contracts	3,482
Total assets	$	4,714
Liabilities:
Floating rate debt	$	301,193
Interest rate swaps	9,152
Foreign currency contracts	—
Total liabilities	$	310,345

	Fair Values at
	February 28, 2019
(in thousands)	(Level 2) (1)
Assets:
Money market accounts	$	915
Interest rate swaps	512
Foreign currency contracts	1,692
Total assets	$	3,119
Liabilities:
Floating rate debt	$	320,784
Interest rate swaps	339
Foreign currency contracts	563
Total liabilities	$	321,686

(1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable.

The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items.

We use derivatives for hedging purposes and our derivatives are primarily interest rate swaps, foreign currency contracts and cross-currency debt swaps.  See Notes 12 and 14 to these condensed consolidated financial statements for more information on our hedging activities.

We classify our floating rate debt as a Level 2 item because the estimation of the fair market value requires the use of a discount rate based upon current market rates of interest for obligations with comparable remaining terms.  Such comparable rates are considered significant other observable market inputs.  The book value of the floating rate debt approximates its fair value as of the reporting date.

Our other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 items.  These assets are measured at fair value on a non-recurring basis as part of our impairment testing.  Note 7 to these condensed consolidated financial statements contains additional information related to intangible asset impairments.

XML

Earnings per Share

6 Months Ended

Aug. 31, 2019

Earnings Per Share [Abstract]

Earnings per Share

Earnings per Share

We compute basic earnings per share using the weighted average number of shares of common stock

outstanding during the period.  We compute diluted earnings per share using the weighted average

number of shares of common stock outstanding plus the effect of dilutive securities.  Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested RSUs, PSUs, RSAs, PSAs and other stock based awards.  See Note 8 to these condensed consolidated financial statements for more information regarding stock-based awards.  Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. 

The following table presents our weighted average basic and diluted shares for the periods shown:

	Three Months Ended August 31,		Six Months Ended August 31,
(in thousands)	2019	2018	2019	2018
Weighted average shares outstanding, basic	25,116	26,359	25,068	26,467
Incremental shares from share-based compensation arrangements	129	198	177	145
Weighted average shares outstanding, diluted	25,245	26,557	25,245	26,612
Antidilutive securities	166	194	259	352

XML

Supplemental Balance Sheet Information (Tables)

6 Months Ended

Aug. 31, 2019

Balance Sheet Related Disclosures [Abstract]

Schedule of property and equipment

PROPERTY AND EQUIPMENT

(in thousands)	Estimated Useful Lives (Years)			August 31, 2019			February 28, 2019
Land		-		$	12,644		$	12,644
Building and improvements	3	-	40	113,619			113,820
Computer, software, furniture and other equipment	3	-	15	86,699			84,711
Tools, molds and other production equipment	3	-	7	37,000			36,378
Construction in progress		-		11,261			6,529
Property and equipment, gross				261,223			254,082
Less accumulated depreciation				(130,059		)	(123,744		)
Property and equipment, net				$	131,164		$	130,338

Schedule of accrued expenses and other current liabilities

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 

(in thousands)	August 31, 2019		February 28, 2019
Accrued compensation, benefits and payroll taxes	$	29,159	$	36,782
Accrued sales discounts and allowances	28,924		28,655
Accrued sales returns	21,359		23,316
Accrued advertising	28,060		26,549
Other	41,769		49,858
Total accrued expenses and other current liabilities	$	149,271	$	165,160

XML

Basis of Presentation and Related Information (Details)	6 Months Ended
	Aug. 31, 2019 Segment $ / shares	Feb. 28, 2019 $ / shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common shares, par value (in dollars per share) | $ / shares	$ 0.10	$ 0.10
Number of segments | Segment	3

XML

Financial Instruments and Risk Management (Tables)

6 Months Ended

Aug. 31, 2019

Financial Instruments, Owned, at Fair Value [Abstract]

Schedule of fair values of derivative instruments

The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:

(in thousands)	August 31, 2019
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- current
Zero-cost dollar - Euro	Cash flow	02/2021	€	16,000	$	207	$	31	$	—	$	—
Foreign currency contracts - sell Euro	Cash flow	12/2020	€	12,750	661		89		—		—
Foreign currency contracts - sell Canadian Dollars	Cash flow	01/2021	$	14,250	125		8		—		—
Zero-cost dollar - Pound	Cash flow	02/2021	£	10,250	237		49		—		—
Foreign currency contracts - sell Pound	Cash flow	02/2021	£	13,500	1,086		195		—		—
Foreign currency contracts - sell Mexican Pesos	Cash flow	02/2020	$	40,000	13		—		—		—
Foreign currency contracts - Sell Australian Dollars	Cash flow	10/2019	$	2,000	46		—		—		—
Interest rate swaps	Cash flow	01/2024	$	225,000	—		—		2,513		6,639
Subtotal					2,375		372		2,513		6,639
Derivatives not designated under hedge accounting
Foreign currency contracts - cross-currency debt swaps - Euro	(1)	04/2020	€	5,280	431		—		—		—
Foreign currency contracts - cross-currency debt swaps - Pound	(1)	04/2020	£	6,395	304		—		—		—
Subtotal					735		—		—		—
Total fair value					$	3,110	$	372	$	2,513	$	6,639

(in thousands)	February 28, 2019
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- current
Zero-cost dollar - Euro	Cash flow	02/2020	€	9,500	$	11	$	—	$	—	$	—
Foreign currency contracts - sell Euro	Cash flow	01/2020	€	29,000	1,047		—		—		—
Foreign currency contracts - sell Canadian Dollars	Cash flow	02/2020	$	16,000	168		—		—		—
Zero-cost dollar - Pound	Cash flow	05/2020	£	4,500	—		—		200		—
Foreign currency contracts - sell Pound	Cash flow	05/2020	£	19,500	248		—		—		13
Foreign currency contracts - sell Mexican Pesos	Cash flow	09/2019	$	30,000	—		—		58		—
Interest rate swaps	Cash flow	01/2024	$	225,000	512		—		—		339
Subtotal					1,986		—		258		352
Derivatives not designated under hedge accounting
Foreign currency contracts - cross-currency debt swaps - Euro	(1)	04/2020	€	5,280	—		218		—		—
Foreign currency contracts - cross-currency debt swaps - Pound	(1)	04/2020	£	6,395	—		—		—		292
Subtotal					—		218		—		292
Total fair value					$	1,986	$	218	$	258	$	644

(1)

These are foreign currency contracts for which we have not elected hedge accounting.  We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements.

Schedule of pre-tax effect of derivative instruments

The following table summarizes the pre-tax effect of derivative instruments for the periods shown:

	Three Months Ended August 31,
	Gain (Loss) Recognized in OCI (effective portion)						Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income							Gain (Loss) Recognized As Income
(in thousands)	2019			2018			Location	2019			2018			Location	2019		2018
Currency contracts - cash flow hedges	$	(482	)	$	(51	)	SG&A	$	(992	)	$	(610	)		$	—	$	—
Interest rate swaps - cash flow hedges	(4,126		)	137			Interest expense	—			—			Interest expense	77		136
Cross-currency debt swaps - principal	—			—				—			—			SG&A	344		243
Cross-currency debt swaps - interest	—			—				—			—			Interest Expense	—		—
Total	$	(4,608	)	$	86			$	(992	)	$	(610	)		$	421	$	379

	Six Months Ended August 31,
	Gain (Loss) Recognized in OCI (effective portion)					Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income						Gain (Loss) Recognized As Income
(in thousands)	2019			2018		Location	2019			2018		Location	2019		2018
Currency contracts - cash flow hedges	$	(668	)	$	4,525	SG&A	$	(2,210	)	$	77		$	—	$	—
Interest rate swaps - cash flow hedges	(9,326		)	76		Interest expense	—			—		Interest expense	231		211
Cross-currency debt swaps - principal	—			—			—			—		SG&A	808		666
Cross-currency debt swaps - interest	—			—			—			—		Interest expense	74		74
Total	$	(9,994	)	$	4,601		$	(2,210	)	$	77		$	1,113	$	951

XML

Repurchase of Helen of Troy Common Stock (Tables)

6 Months Ended

Aug. 31, 2019

Equity [Abstract]

Summary of share repurchase activity

The following table summarizes our share repurchase activity for the periods shown:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands, except share and per share data)	2019		2018		2019		2018
Common stock repurchased on the open market:
Number of shares	—		—		—		407,025
Aggregate value of shares	$	—	$	—	$	—	$	37,067
Average price per share	$	—	$	—	$	—	$	91.07
Common stock received in connection with share-based compensation:
Number of shares	2,354		7,477		70,558		57,072
Aggregate value of shares	$	344	$	692	$	9,131	$	5,173
Average price per share	$	145.96	$	92.55	$	129.42	$	90.65

XML

Label	Element	Value
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	$ 37,082,000
Non-Cash Increase (Decrease) In Other Accrued Liabilities	hele_NonCashIncreaseDecreaseInOtherAccruedLiabilities	(2,873,000)
Non-Cash Increase (Decrease) In Other Current Assets And Liabilities, Net	hele_NonCashIncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet	(7,311,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(9,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(167,000)
Non-Cash Increase (Decrease) In Prepaid Expense And Other Assets	hele_NonCashIncreaseDecreaseInPrepaidExpenseAndOtherAssets	43,000
Additional Paid-in Capital [Member]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(2,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	1,000
Retained Earnings [Member]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(161,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(9,000)
Common Stock [Member]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(4,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	$ (1,000)

XML

Discontinued Operations

6 Months Ended

Aug. 31, 2019

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued OperationsIn December 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries ("Healthy Directions") to Direct Digital, LLC. The purchase price from the sale was comprised of $46.0 million in cash, which was paid at closing, and a supplemental payment with a target value of $25.0 million, payable on or before August 1, 2019.  During fiscal 2019, the final amount of the supplemental payment was adjusted to $10.8 million based on a settlement with respect to the calculation of the performance of Healthy Directions through February 28, 2018. The adjustment resulted in a corresponding pre-tax charge of $5.8 million ($4.4 million after tax) to discontinued operations. The supplemental payment of $10.8 million was received during the second quarter of fiscal 2020. Also, during fiscal 2019, we recorded additional net charges of $1.5 million ($1.3 million after tax) to discontinued operations, resulting from the resolution of certain contingencies. In conjunction with the sale of the business, we provided certain transition services that ceased during the second quarter of fiscal 2020.

XML

Repurchases of Helen of Troy Common Stock

6 Months Ended

Aug. 31, 2019

Equity [Abstract]

Repurchase of Helen of Troy Common Stock

Repurchase of Helen of Troy Common Stock

On May 20, 2019, we announced that our Board of Directors had authorized the repurchase of up to $400 million of our outstanding common stock.  The authorization is effective May 8, 2019 for a period of three years and replaced Helen of Troy's previous repurchase authorization, of which approximately $107.4 million remained. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities.  As of August 31, 2019, our repurchase authorization allowed for the purchase of $394.0 million of common stock. 

Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants.  In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the equity holder can be paid for by having the equity holder tender back to the Company a number of shares at fair value equal to the amounts due.  Net exercises are treated as purchases and retirements of shares.

The following table summarizes our share repurchase activity for the periods shown:

	Three Months Ended August 31,				Six Months Ended August 31,
(in thousands, except share and per share data)	2019		2018		2019		2018
Common stock repurchased on the open market:
Number of shares	—		—		—		407,025
Aggregate value of shares	$	—	$	—	$	—	$	37,067
Average price per share	$	—	$	—	$	—	$	91.07
Common stock received in connection with share-based compensation:
Number of shares	2,354		7,477		70,558		57,072
Aggregate value of shares	$	344	$	692	$	9,131	$	5,173
Average price per share	$	145.96	$	92.55	$	129.42	$	90.65

XML

Goodwill and Intangible Assets - Summary of amortization expense attributable to intangible assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Aggregate Amortization Expense	$ 4,463	$ 3,402	$ 8,339	$ 7,522

XML

Repurchase of Helen of Troy Common Stock (Details) - USD ($)		3 Months Ended		6 Months Ended
	May 08, 2019	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018	May 20, 2019
Repurchase of common stock
Amount of shares authorized for purchase						$ 400,000,000
Period for stock repurchase	3 years
Remaining share repurchase amount - prior program	$ 107,400,000
Remaining share repurchase amount		$ 394,000,000.0		$ 394,000,000.0
Repurchase of common stock
Number of shares (in shares)		2,354,000	7,477,000	70,558,000	57,072,000
Aggregate value of shares (in USD)		$ 343,000	$ 692,000	$ 9,131,000	$ 42,240,000
Average price per share (in dollars per share)		$ 145.96	$ 92.55	$ 129.42	$ 90.65
Open market or tender offer
Repurchase of common stock
Number of shares (in shares)		0	0	0	407,025,000
Aggregate value of shares (in USD)		$ 0	$ 0	$ 0	$ 37,067,000
Average price per share (in dollars per share)		$ 0	$ 0	$ 0	$ 91.07
Stock Compensation Plan
Repurchase of common stock
Aggregate value of shares (in USD)		$ 344,000	$ 692,000	$ 9,131,000	$ 5,173,000

XML

Long-Term Debt - Schedule (Details)	3 Months Ended	6 Months Ended
	Aug. 31, 2018	Aug. 31, 2019 USD ($) method	Aug. 31, 2018
Minimum | Credit agreement
Long-term debt
Interest rate range during each year (as a percent)	2.90%	3.10%	2.80%
Maximum | Credit agreement
Long-term debt
Interest rate range during each year (as a percent)	5.00%	5.50%	5.00%
MBFC loan
Long-term debt
Remaining principal balance due on March 1, 2023		$ 14,800,000
Credit agreement
Long-term debt
Maximum revolving commitment		$ 1,000,000,000.0
Number of alternative methods under which interest on borrowings accrue | method		2
Amount available for borrowings		$ 708,000,000.0
Maximum additional debt allowed under debt covenants		609,000,000.0
Revolving loan | Credit agreement
Long-term debt
Amount outstanding		283,000,000.0
Letter of credit | Credit agreement
Long-term debt
Amount outstanding		$ 9,000,000.0

XML

Fair Value (Tables)

6 Months Ended

Aug. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of fair value hierarchy of financial assets and liabilities presented at fair value and measured on a recurring basis

The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown:

	Fair Values at
	August 31, 2019
(in thousands)	(Level 2) (1)
Assets:
Money market accounts	$	1,232
Interest rate swaps	—
Foreign currency contracts	3,482
Total assets	$	4,714
Liabilities:
Floating rate debt	$	301,193
Interest rate swaps	9,152
Foreign currency contracts	—
Total liabilities	$	310,345

	Fair Values at
	February 28, 2019
(in thousands)	(Level 2) (1)
Assets:
Money market accounts	$	915
Interest rate swaps	512
Foreign currency contracts	1,692
Total assets	$	3,119
Liabilities:
Floating rate debt	$	320,784
Interest rate swaps	339
Foreign currency contracts	563
Total liabilities	$	321,686

(1)

Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable.

XML

Share-Based Compensation Plans (Tables)

6 Months Ended

Aug. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based compensation expense in SG&A

We recorded the following share-based compensation expense in SG&A for the periods shown below: 

	Three Months Ended August 31,
(in thousands, except per share data)	2019			2018
Stock options	$	35		$	219
Directors stock compensation	141			123
Performance based and other stock awards	6,205			4,347
Employee stock purchase plan	—			—
Share-based compensation expense	6,381			4,689
Less income tax benefits	(514		)	(341		)
Share-based compensation expense, net of income tax benefits	$	5,867		$	4,348
Impact of share-based compensation on earnings per share from continuing operations:
Basic	$	0.23		$	0.16
Diluted	$	0.23		$	0.16

	Six Months Ended August 31,
(in thousands, except per share data)	2019			2018
Stock options	$	151		$	527
Directors stock compensation	281			246
Performance based and other stock awards	13,228			9,918
Employee stock purchase plan	325			322
Share-based compensation expense	13,985			11,013
Less income tax benefits	(1,091		)	(611		)
Share-based compensation expense, net of income tax benefits	$	12,894		$	10,402
Impact of share-based compensation on earnings per share from continuing operations:
Basic	$	0.51		$	0.39
Diluted	$	0.51		$	0.39

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

6 Months Ended

Aug. 31, 2019

Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown:

(in thousands)	Interest Rate Swaps			Foreign Currency Contracts			Total
Balance at February 28, 2018	$	1,705		$	(1,074	)	$	631
Other comprehensive income (loss) before reclassification	76			4,525			4,601
Amounts reclassified out of accumulated other comprehensive income	—			(77		)	(77		)
Tax effects	129			(637		)	(508		)
Other comprehensive income (loss)	205			3,811			4,016
Balance at August 31, 2018	$	1,910		$	2,737		$	4,647
Balance at February 28, 2019	$	132		$	1,059		$	1,191
Other comprehensive income (loss) before reclassification	(9,326		)	(668		)	(9,994		)
Amounts reclassified out of accumulated other comprehensive income	—			2,210			2,210
Tax effects	2,165			(327		)	1,838
Other comprehensive income (loss)	(7,161		)	1,215			(5,946		)
Balance at August 31, 2019	$	(7,029	)	$	2,274		$	(4,755	)

XML

Supplemental Balance Sheet Information

6 Months Ended

Aug. 31, 2019

Balance Sheet Related Disclosures [Abstract]

Supplemental Balance Sheet Information

Supplemental Balance Sheet Information

PROPERTY AND EQUIPMENT

(in thousands)	Estimated Useful Lives (Years)			August 31, 2019			February 28, 2019
Land		-		$	12,644		$	12,644
Building and improvements	3	-	40	113,619			113,820
Computer, software, furniture and other equipment	3	-	15	86,699			84,711
Tools, molds and other production equipment	3	-	7	37,000			36,378
Construction in progress		-		11,261			6,529
Property and equipment, gross				261,223			254,082
Less accumulated depreciation				(130,059		)	(123,744		)
Property and equipment, net				$	131,164		$	130,338

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 

(in thousands)	August 31, 2019		February 28, 2019
Accrued compensation, benefits and payroll taxes	$	29,159	$	36,782
Accrued sales discounts and allowances	28,924		28,655
Accrued sales returns	21,359		23,316
Accrued advertising	28,060		26,549
Other	41,769		49,858
Total accrued expenses and other current liabilities	$	149,271	$	165,160

XML

Restructuring Plan

6 Months Ended

Aug. 31, 2019

Restructuring and Related Activities [Abstract]

Restructuring Plan

Restructuring Plan

In October 2017, we announced that we had approved a restructuring plan (referred to as “Project Refuel”). Project Refuel includes a reduction-in-force and the elimination of certain contracts and operating expenses.  We are targeting total annualized profit improvements of approximately $8.0 to $10.0 million over the duration of the plan.  We estimate the plan will be completed during fiscal 2020, and expect to incur total restructuring charges of approximately $7.0 million over the duration of the plan. Restructuring provisions are determined based on estimates prepared at the time the restructuring actions are approved by management and are revised periodically.

For the three and six month periods ended August 31, 2019, we incurred $0.4 million and $1.0 million, respectively, of pre-tax restructuring charges related primarily to employee severance and termination benefits and lease termination costs. Since implementing Project Refuel, we have incurred $6.4 million of pre-tax restructuring costs related to employee severance and termination benefits and contract termination costs as of August 31, 2019. During the three and six month periods ended August 31, 2019, we made total cash restructuring payments of $0.9 million and $1.5 million, respectively. Since implementing Project Refuel, we have made total cash restructuring payments of $5.8 million. We had a remaining liability of $0.7 million as of August 31, 2019.

XML

Long-Term Debt - Summary of long-term debt (Details) - USD ($)	6 Months Ended
	Aug. 31, 2019	Feb. 28, 2019
Debt Instrument [Line Items]
Total long-term debt	$ 301,193,000	$ 320,784,000
Less current maturities of long-term debt	(1,884,000)	(1,884,000)
Long-term debt, excluding current maturities	299,309,000	318,900,000
MBFC loan
Debt Instrument [Line Items]
Total long-term debt	20,443,000	22,335,000
MBFC Loan original balance	37,600,000
Remaining principal balance due on March 1, 2020	1,900,000
Remaining principal balance due on March 1, 2021	1,900,000
Remaining principal balance due on March 1, 2022	1,900,000
Remaining principal balance due on March 1, 2023	$ 14,800,000
MBFC loan | LIBOR | Maximum
Debt Instrument [Line Items]
Interest rate	2.00%
MBFC loan | Base rate
Debt Instrument [Line Items]
Interest rate	1.00%
Credit agreement
Debt Instrument [Line Items]
Total long-term debt	$ 280,750,000	$ 298,449,000
Amount of interest rate swap hedge	$ 225,000,000

XML

Goodwill and Intangible Assets - Schedule of estimated amortization expense of intangible assets (Details) $ in Thousands	Aug. 31, 2019 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Fiscal 2020	$ 17,691
Fiscal 2021	16,135
Fiscal 2022	9,037
Fiscal 2023	8,847
Fiscal 2024	8,441
Fiscal 2025	$ 6,977

XML

Restructuring Plan (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018	Feb. 29, 2020
Restructuring Plan
Restructuring charges	$ 430	$ 859	$ 1,049	$ 2,584
Cash restructuring payments for the reporting period	900		1,500
Project Refuel
Restructuring Plan
Restructuring charges	400		1,000
Incurred pre-tax restructuring costs	6,400		6,400
Cash restructuring payments to date			5,800
Restructuring liability	$ 700		700
Minimum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement			8,000
Maximum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement			$ 10,000
Scenario, Forecast | Project Refuel
Restructuring Plan
Restructuring charges					$ 7,000

XML

Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands	Aug. 31, 2019 USD ($)	Aug. 31, 2019 CAD ($)	Aug. 31, 2019 MXN ($)	Aug. 31, 2019 EUR (€)	Aug. 31, 2019 GBP (£)	Aug. 31, 2019 AUD ($)	May 31, 2019 USD ($)	Feb. 28, 2019 USD ($)	Feb. 28, 2019 CAD ($)	Feb. 28, 2019 MXN ($)	Feb. 28, 2019 EUR (€)	Feb. 28, 2019 GBP (£)
Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	$ 3,110,000							$ 1,986,000
Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	372,000							218,000
Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	2,513,000							258,000
Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	6,639,000							644,000
Derivatives designated as hedging instruments | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	2,375,000							1,986,000
Derivatives designated as hedging instruments | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	372,000							0
Derivatives designated as hedging instruments | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	2,513,000							258,000
Derivatives designated as hedging instruments | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	6,639,000							352,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | €				€ 12,750							€ 29,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	661,000							1,047,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	89,000							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional amount		$ 14,250							$ 16,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	125,000							168,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	8,000							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | £					£ 13,500							£ 19,500
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	1,086,000							248,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	195,000							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							13,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos
Fair values of derivative instruments in the consolidated balance sheet
Notional amount			$ 40,000							$ 30,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	13,000							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	0							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							58,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional amount						$ 2,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	46,000
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0
Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets							$ 207,000	11,000
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets							31,000	0
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities							0	0
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities							$ 0	0
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount				16,000	10,250						9,500	4,500
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	237,000							0
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	49,000							0
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							200,000
Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives designated as hedging instruments | Interest rate swaps
Fair values of derivative instruments in the consolidated balance sheet
Notional amount	225,000,000							225,000,000
Derivatives designated as hedging instruments | Interest rate swaps | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	0							512,000
Derivatives designated as hedging instruments | Interest rate swaps | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	0							0
Derivatives designated as hedging instruments | Interest rate swaps | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	2,513,000							0
Derivatives designated as hedging instruments | Interest rate swaps | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	6,639,000							339,000
Derivatives not designated under hedge accounting | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	735,000							0
Derivatives not designated under hedge accounting | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	0							218,000
Derivatives not designated under hedge accounting | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives not designated under hedge accounting | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							292,000
Derivatives not designated under hedge accounting | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets								218,000
Derivatives not designated under hedge accounting | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets								0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | €				€ 5,280							€ 5,280
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	431,000							0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional amount | £					£ 6,395							£ 6,395
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Prepaid expenses and other current assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	304,000							0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets	0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Accrued expenses and other current liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	0							0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other liabilities, non-current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities	$ 0							$ 292,000

XML

Earnings per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Weighted average diluted securities
Weighted average shares outstanding, basic (in shares)	25,116	26,359	25,068	26,467
Incremental shares from share-based payment arrangements (in shares)	129	198	177	145
Weighted average shares outstanding, diluted (in shares)	25,245	26,557	25,245	26,612
Stock options
Weighted average diluted securities
Antidilutive securities (in shares)	166	194	259	352

XML

Basis of Presentation and Related Information

6 Months Ended

Aug. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Related Information

Basis of Presentation and Related Information

The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2019 and February 28, 2019, and the results of our consolidated operations for the interim periods presented.  We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2019, and our other reports on file with the Securities and Exchange Commission (“SEC”).

When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. We refer to our common shares, par value $0.10 per share, as “common stock.” References to the "FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to United States (“U.S.”) generally accepted accounting principles.  References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB.  References to "ASC" refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.

We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994.  We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products.  We have three segments: Housewares, Health & Home, and Beauty.  Our Housewares segment provides a broad range of innovative consumer products for the home.  Product offerings include food preparation tools and storage containers; cleaning, bath and garden tools and accessories; infant and toddler care products; and insulated beverage, food containers and coolers.  The Health & Home segment focuses on health care devices such as thermometers, humidifiers, blood pressure monitors, and heating pads; water filtration systems; and small home appliances such as portable heaters, fans, air purifiers, and insect control devices.  Our Beauty segment products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid-, solid- and powder-based personal care and grooming products.

On December 20, 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries to Direct Digital, LLC.  The results of the Nutritional Supplements operations have been reported as discontinued operations for all periods presented in the consolidated financial statements.  For more information, see Note 5 to these condensed consolidated financial statements.  All other notes present results from continuing operations.

Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30^th.  We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States.

Our condensed consolidated financial statements are prepared in U.S. Dollars.  All intercompany accounts and transactions are eliminated in consolidation.

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

We have reclassified, combined or separately disclosed certain amounts in the prior years’ condensed consolidated financial statements and accompanying footnotes to conform with the current period’s presentation.

XML

Leases - Schedule of Lease Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Mar. 01, 2019
Leases [Abstract]
Lease liabilities, current	$ 3,155
Lease liabilities, non-current	42,470
Total lease liability	$ 45,625	$ 47,223

XML

New Accounting Pronouncements - Adopted (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Mar. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease assets	$ 34,429
Initial recognition of lease liabilities	$ (45,625)	$ (47,223)
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease assets		37,100
Initial recognition of lease liabilities		$ (47,200)

XML

Goodwill and Intangible Assets - Schedule of carrying amounts and associated accumulated amortization for all intangible assets by operating segment (Details) - USD ($) $ in Thousands	Aug. 31, 2019	May 31, 2019	Feb. 28, 2019
Changes in Goodwill
Cumulative goodwill impairments	$ (46,490)		$ (46,490)
Goodwill net book value	602,320		602,320
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(189,771)		(181,463)
Goodwill and intangible assets
Gross carrying amount	1,121,767		1,121,799
Net book value	885,506		893,846
Housewares
Changes in Goodwill
Goodwill gross carrying amount	282,056		282,056
Cumulative goodwill impairments	0		0
Goodwill net book value	282,056		282,056
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(20,066)		(19,398)
Goodwill and intangible assets
Gross carrying amount	457,584		457,673
Net book value	437,518		438,275
Housewares | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	41,328		41,417
Intangible assets - finite-lived, accumulated amortization	(20,066)		(19,398)
Intangible assets - finite-lived, net book value	21,262		22,019
Housewares | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	134,200		134,200
Health and Home
Changes in Goodwill
Goodwill gross carrying amount	284,913		284,913
Cumulative goodwill impairments	0		0
Goodwill net book value	284,913		284,913
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(108,950)		(103,355)
Goodwill and intangible assets
Gross carrying amount	481,387		481,330
Net book value	372,437		377,975
Health and Home | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	17,050		17,050
Intangible assets - finite-lived, accumulated amortization	(15,577)		(15,402)
Intangible assets - finite-lived, net book value	1,473		1,648
Health and Home | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	118,024		117,967
Intangible assets - finite-lived, accumulated amortization	(93,373)		(87,953)
Intangible assets - finite-lived, net book value	24,651		30,014
Health and Home | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	54,000		54,000
Health and Home | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	7,400		7,400
Beauty
Changes in Goodwill
Goodwill gross carrying amount	81,841		81,841
Cumulative goodwill impairments	(46,490)		(46,490)
Goodwill net book value	35,351		35,351
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(60,755)		(58,710)
Goodwill and intangible assets
Gross carrying amount	182,796		182,796
Net book value	75,551		77,596
Beauty | Trademarks
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	30,557		150
Intangible assets - finite-lived, accumulated amortization	(1,956)		(102)
Intangible assets - finite-lived, net book value	28,601	$ 30,400	48
Beauty | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	13,696		13,696
Intangible assets - finite-lived, accumulated amortization	(12,641)		(12,482)
Intangible assets - finite-lived, net book value	1,055		1,214
Beauty | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	46,402		46,402
Intangible assets - finite-lived, accumulated amortization	(46,158)		(46,126)
Intangible assets - finite-lived, net book value	244		276
Beauty | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	0		30,407
Beauty | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	$ 10,300		$ 10,300

XML

Consolidated Condensed Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Income Statement [Abstract]
Sales revenue, net	$ 413,995	$ 393,548	$ 790,330	$ 748,227
Cost of goods sold	235,844	238,375	458,452	446,496
Gross profit	178,151	155,173	331,878	301,731
Selling, general and administrative expense (SG&A)	123,201	103,654	229,102	205,160
Restructuring charges	430	859	1,049	2,584
Operating income	54,520	50,660	101,727	93,987
Non-operating income, net	89	85	221	160
Interest expense	(3,216)	(2,755)	(6,524)	(5,442)
Income before income tax	51,393	47,990	95,424	88,705
Income tax expense	5,298	3,973	8,635	6,515
Income from continuing operations	46,095	44,017	86,789	82,190
Loss from discontinued operations, net of tax	0	0	0	(381)
Net income	$ 46,095	$ 44,017	$ 86,789	$ 81,809
Earnings (loss) per share - basic:
Continuing operations (in dollars per share)	$ 1.84	$ 1.67	$ 3.46	$ 3.11
Discontinued operations (in dollars per share)	0	0	0	(0.01)
Total earnings per share - basic (in dollars per share)	1.84	1.67	3.46	3.09
Earnings (loss) per share - diluted:
Continuing operations (in dollars per share)	1.83	1.66	3.44	3.09
Discontinued operations (in dollars per share)	0	0	0	(0.01)
Total earnings per share - diluted (in dollars per share)	$ 1.83	$ 1.66	$ 3.44	$ 3.07
Weighted average shares of common stock used in computing earnings per share:
Basic (in shares)	25,116	26,359	25,068	26,467
Diluted (in shares)	25,245	26,557	25,245	26,612

XML

Goodwill and Intangible Assets (Tables)

6 Months Ended

Aug. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of carrying amounts and associated accumulated amortization for all intangible assets by operating segment

The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented:

	August 31, 2019										February 28, 2019
(in thousands)	Gross Carrying Amount		Cumulative Goodwill Impairments			Accumulated Amortization			Net Book Value		Gross Carrying Amount		Cumulative Goodwill Impairments			Accumulated Amortization			Net Book Value
Housewares:
Goodwill	$	282,056	$	—		$	—		$	282,056	$	282,056	$	—		$	—		$	282,056
Trademarks - indefinite	134,200		—			—			134,200		134,200		—			—			134,200
Other intangibles - finite	41,328		—			(20,066		)	21,262		41,417		—			(19,398		)	22,019
Subtotal	457,584		—			(20,066		)	437,518		457,673		—			(19,398		)	438,275
Health & Home:
Goodwill	284,913		—			—			284,913		284,913		—			—			284,913
Trademarks - indefinite	54,000		—			—			54,000		54,000		—			—			54,000
Licenses - finite	17,050		—			(15,577		)	1,473		17,050		—			(15,402		)	1,648
Licenses - indefinite	7,400		—			—			7,400		7,400		—			—			7,400
Other intangibles - finite	118,024		—			(93,373		)	24,651		117,967		—			(87,953		)	30,014
Subtotal	481,387		—			(108,950		)	372,437		481,330		—			(103,355		)	377,975
Beauty:
Goodwill	81,841		(46,490		)	—			35,351		81,841		(46,490		)	—			35,351
Trademarks - indefinite	—		—			—			—		30,407		—			—			30,407
Trademarks - finite	30,557		—			(1,956		)	28,601		150		—			(102		)	48
Licenses - indefinite	10,300		—			—			10,300		10,300		—			—			10,300
Licenses - finite	13,696		—			(12,641		)	1,055		13,696		—			(12,482		)	1,214
Other intangibles - finite	46,402		—			(46,158		)	244		46,402		—			(46,126		)	276
Subtotal	182,796		(46,490		)	(60,755		)	75,551		182,796		(46,490		)	(58,710		)	77,596
Total	$	1,121,767	$	(46,490	)	$	(189,771	)	$	885,506	$	1,121,799	$	(46,490	)	$	(181,463	)	$	893,846

Summary of amortization expense attributable to intangible assets

The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2020 through 2025:

Aggregate Amortization Expense
For the three months ended (in thousands)
August 31, 2019	$	4,463
August 31, 2018	3,402

Aggregate Amortization Expense
For the six months ended (in thousands)
August 31, 2019	$	8,339
August 31, 2018	7,522

Schedule of estimated amortization expense of intangible assets

Estimated Amortization Expense (in thousands)
Fiscal 2020	$	17,691
Fiscal 2021	16,135
Fiscal 2022	9,037
Fiscal 2023	8,847
Fiscal 2024	8,441
Fiscal 2025	6,977

XML

Financial Instruments and Risk Management

6 Months Ended

Aug. 31, 2019

Financial Instruments, Owned, at Fair Value [Abstract]

Financial Instruments and Risk Management

Financial Instruments and Risk Management

Foreign Currency Risk - Our functional currency is the U.S. Dollar.  By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”).  Such transactions include sales, certain inventory purchases and operating expenses.  As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies.  During the three and six month periods ended August 31, 2019, approximately 14% and 13% of our net sales revenue was in foreign currencies, respectively. During the three and six month periods ended August 31, 2018, approximately 11% and 13% of our net sales revenue was in foreign currencies, respectively. These sales were primarily denominated in Euros, British Pounds, Canadian Dollars, and Mexican Pesos. We make most of our inventory purchases from the Far East and primarily use the U.S. Dollar for such purchases.

In our condensed consolidated statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities are recognized in their respective income tax lines, and all other foreign exchange gains and losses are recognized in SG&A.  During the three and six month periods ended August 31, 2019, we recorded net foreign exchange gains from remeasurement, including the impact of currency hedges and the cross-currency debt swaps, of $0.8 million and $1.6 million, respectively, in SG&A. We recorded net foreign

exchange gains from remeasurement, including the impact of foreign currency hedges and cross currency debt swaps of $0.5 million and losses of $1.2 million in SG&A during the three and six month periods ended August 31, 2018, respectively.

We hedge against certain foreign currency exchange rate-risk by using a series of forward contracts and zero-cost collars designated as cash flow hedges and mark-to-market derivatives to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar. We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes. The effective portion of the changes in fair value of these instruments is reported in OCI and reclassified into SG&A in the same period they are settled. The ineffective portion, which is not material for any year presented, is immediately recognized in SG&A.

Interest Rate Risk - Interest on our outstanding debt as of August 31, 2019 is based on floating interest rates.  If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225.0 million of the outstanding principal balance under the Credit Agreement, which totaled $283.0 million (excluding prepaid finance fees) as of August 31, 2019.

The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:

(in thousands)	August 31, 2019
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- current
Zero-cost dollar - Euro	Cash flow	02/2021	€	16,000	$	207	$	31	$	—	$	—
Foreign currency contracts - sell Euro	Cash flow	12/2020	€	12,750	661		89		—		—
Foreign currency contracts - sell Canadian Dollars	Cash flow	01/2021	$	14,250	125		8		—		—
Zero-cost dollar - Pound	Cash flow	02/2021	£	10,250	237		49		—		—
Foreign currency contracts - sell Pound	Cash flow	02/2021	£	13,500	1,086		195		—		—
Foreign currency contracts - sell Mexican Pesos	Cash flow	02/2020	$	40,000	13		—		—		—
Foreign currency contracts - Sell Australian Dollars	Cash flow	10/2019	$	2,000	46		—		—		—
Interest rate swaps	Cash flow	01/2024	$	225,000	—		—		2,513		6,639
Subtotal					2,375		372		2,513		6,639
Derivatives not designated under hedge accounting
Foreign currency contracts - cross-currency debt swaps - Euro	(1)	04/2020	€	5,280	431		—		—		—
Foreign currency contracts - cross-currency debt swaps - Pound	(1)	04/2020	£	6,395	304		—		—		—
Subtotal					735		—		—		—
Total fair value					$	3,110	$	372	$	2,513	$	6,639

(in thousands)	February 28, 2019
Derivatives designated as hedging instruments	Hedge Type	Final Settlement Date	Notional Amount		Prepaid Expenses and Other Current Assets		Other Assets		Accrued Expenses and Other Current Liabilities		Other Liabilities, Non- current
Zero-cost dollar - Euro	Cash flow	02/2020	€	9,500	$	11	$	—	$	—	$	—
Foreign currency contracts - sell Euro	Cash flow	01/2020	€	29,000	1,047		—		—		—
Foreign currency contracts - sell Canadian Dollars	Cash flow	02/2020	$	16,000	168		—		—		—
Zero-cost dollar - Pound	Cash flow	05/2020	£	4,500	—		—		200		—
Foreign currency contracts - sell Pound	Cash flow	05/2020	£	19,500	248		—		—		13
Foreign currency contracts - sell Mexican Pesos	Cash flow	09/2019	$	30,000	—		—		58		—
Interest rate swaps	Cash flow	01/2024	$	225,000	512		—		—		339
Subtotal					1,986		—		258		352
Derivatives not designated under hedge accounting
Foreign currency contracts - cross-currency debt swaps - Euro	(1)	04/2020	€	5,280	—		218		—		—
Foreign currency contracts - cross-currency debt swaps - Pound	(1)	04/2020	£	6,395	—		—		—		292
Subtotal					—		218		—		292
Total fair value					$	1,986	$	218	$	258	$	644

(1) These are foreign currency contracts for which we have not elected hedge accounting.  We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. 

The following table summarizes the pre-tax effect of derivative instruments for the periods shown:

	Three Months Ended August 31,
	Gain (Loss) Recognized in OCI (effective portion)						Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income							Gain (Loss) Recognized As Income
(in thousands)	2019			2018			Location	2019			2018			Location	2019		2018
Currency contracts - cash flow hedges	$	(482	)	$	(51	)	SG&A	$	(992	)	$	(610	)		$	—	$	—
Interest rate swaps - cash flow hedges	(4,126		)	137			Interest expense	—			—			Interest expense	77		136
Cross-currency debt swaps - principal	—			—				—			—			SG&A	344		243
Cross-currency debt swaps - interest	—			—				—			—			Interest Expense	—		—
Total	$	(4,608	)	$	86			$	(992	)	$	(610	)		$	421	$	379

	Six Months Ended August 31,
	Gain (Loss) Recognized in OCI (effective portion)					Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income						Gain (Loss) Recognized As Income
(in thousands)	2019			2018		Location	2019			2018		Location	2019		2018
Currency contracts - cash flow hedges	$	(668	)	$	4,525	SG&A	$	(2,210	)	$	77		$	—	$	—
Interest rate swaps - cash flow hedges	(9,326		)	76		Interest expense	—			—		Interest expense	231		211
Cross-currency debt swaps - principal	—			—			—			—		SG&A	808		666
Cross-currency debt swaps - interest	—			—			—			—		Interest expense	74		74
Total	$	(9,994	)	$	4,601		$	(2,210	)	$	77		$	1,113	$	951

We expect pre-tax losses of $0.1 million associated with foreign currency contracts and interest rate swaps currently reported in accumulated other comprehensive income, to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle. 

Counterparty Credit Risk - Financial instruments, including foreign currency contracts and cross currency debt swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. Although our

theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit losses is remote.

XML

Accumulated Other Comprehensive income (Loss)

6 Months Ended

Aug. 31, 2019

Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]

Accumulated Other Comprehensive Income (Loss)

Accumulated Other Comprehensive Income (Loss)

The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown:

(in thousands)	Interest Rate Swaps			Foreign Currency Contracts			Total
Balance at February 28, 2018	$	1,705		$	(1,074	)	$	631
Other comprehensive income (loss) before reclassification	76			4,525			4,601
Amounts reclassified out of accumulated other comprehensive income	—			(77		)	(77		)
Tax effects	129			(637		)	(508		)
Other comprehensive income (loss)	205			3,811			4,016
Balance at August 31, 2018	$	1,910		$	2,737		$	4,647
Balance at February 28, 2019	$	132		$	1,059		$	1,191
Other comprehensive income (loss) before reclassification	(9,326		)	(668		)	(9,994		)
Amounts reclassified out of accumulated other comprehensive income	—			2,210			2,210
Tax effects	2,165			(327		)	1,838
Other comprehensive income (loss)	(7,161		)	1,215			(5,946		)
Balance at August 31, 2019	$	(7,029	)	$	2,274		$	(4,755	)

See Notes 12, 13 and 14 to these condensed consolidated financial statements for additional information regarding our hedging activities.

XML

Leases

6 Months Ended

Aug. 31, 2019

Leases [Abstract]

Leases

Leases

Adoption of the new lease standard resulted in the recording of lease assets and lease liabilities of approximately $37.1 million and $47.2 million, respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to unamortized lease incentives and deferred rent recorded in accordance with the previous lease guidance. The new standard did not materially impact our consolidated statements of income or cash flows.

The Company primarily has leases for office space, which are classified as operating leases. Operating leases are included in operating lease assets, accrued expenses and other current liabilities, and lease liabilities, non-current in our consolidated balance sheets. Operating lease assets and operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As most of our lease contracts do not provide an explicit interest rate, we use an estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

We include options to extend or terminate the lease in the lease term for accounting considerations, when it is reasonably certain that we will exercise that option. Our leases have remaining lease terms of 1 to 14 years.  Lease expense for lease payments is recognized on a straight-line basis over the lease term in a manner similar to previous accounting guidance. We do not recognize leases with an initial term of twelve months or less on the balance sheet and instead recognize the related lease payments as expense in the condensed consolidated statements of income on a straight-line basis over the lease term. We account for lease and non-lease components as a single lease component for all asset classes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Under the new guidance, operating lease expense recognized in the condensed consolidated statements of income during the three and six month periods ended August 31, 2019 was $1.7 million and $3.3 million, respectively.  Short-term lease expense is excluded from this amount and is not material.  The non-cash component of lease expense is included as an adjustment to reconcile income from continuing operations to net cash provided by operating activities in the condensed consolidated statements of cash flows.

A summary of supplemental lease information is as follows:

	August 31, 2019
Weighted average remaining lease term (years)	11.1
Weighted average discount rate	6.09		%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,112

A summary of our estimated lease payments, imputed interest and liabilities are as follows:

(in thousands)
Fiscal 2020 (balance for remainder of fiscal year)	$	2,470
Fiscal 2021	6,082
Fiscal 2022	5,959
Fiscal 2023	5,601
Fiscal 2024	5,102
Thereafter	40,132
Total future lease payments	65,346
Less: imputed interest	(19,721		)
Present value of lease liability	$	45,625

	August 31, 2019
Lease liabilities, current (1)	$	3,155
Lease liabilities, non-current	42,470
Total lease liability	$	45,625

(1) Included as part of "Accrued expenses and other current liabilities" on the condensed consolidated balance sheet.

XML

Share-Based Compensation Plans

6 Months Ended

Aug. 31, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation Plans

Share-Based Compensation Plans

We have equity awards outstanding under several share-based compensation plans. During the three and six months ended August 31, 2019, we had the following share-based compensation activity:

• We issued 1,048 and 2,304 shares to non-employee Board members with a total grant date fair value of $0.1 and $0.2 million, respectively, and share prices of $134.21 and $121.99, respectively.

• We granted time-vested restricted stock units ("RSUs") that may be settled for 8 and 3,279 shares of common stock, respectively. The RSU grants have a weighted average grant price of $150.86 and $111.51 per share, respectively. For the three months ended August 31, 2019, the total award fair value was insignificant. For the six months ended August 31, 2019, the total award fair value at date of grant was $0.4 million.

• We granted time-vested restricted stock awards ("RSAs") that may be vested for 4,920 and 45,772 shares of common stock, respectively. The RSA grants have a weighted average grant price of $138.86 and $113.98 per share, respectively, for a total award fair value at date of grant of $0.7 million and $5.2 million, respectively.

• There were no grants of performance-based stock units ("PSUs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSUs that may be settled for 6,088 shares of common stock. The PSU grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $0.7 million.

• There were no grants of performance-based restricted stock awards ("PSAs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSAs that are targeted to be vested for 122,402 shares of common stock. The PSA grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $13.6 million.

• RSUs for 3,489 and 66,329 shares vested and settled, respectively, with a total fair value at settlement of $0.5 and $7.6 million and a weighted average share price of $146.26 and $114.58, respectively.  

• There were no PSUs shares vested and settled during the three months ended August 31, 2019. For the six months ended August 31, 2019, there were 108,572 shares vested and settled with a total fair value at settlement of $14.7 million, and a weighted average share price of $135.85.

• RSAs for 928 shares vested and settled with a total fair value at settlement of $0.1 million and a weighted average share price of $150.86 during the three and six month periods ended August 31, 2019.

• Employees exercised stock options to purchase 26,368 and 61,765 shares of common stock, respectively.

• There were no purchases of common stock under the employee stock purchase plan during the three months ended August 31, 2019. For the six months ended August 31, 2019, employees purchased 14,790 shares of common stock under the employee stock purchase plan at an average price of $95.29 per share.

We recorded the following share-based compensation expense in SG&A for the periods shown below: 

	Three Months Ended August 31,
(in thousands, except per share data)	2019			2018
Stock options	$	35		$	219
Directors stock compensation	141			123
Performance based and other stock awards	6,205			4,347
Employee stock purchase plan	—			—
Share-based compensation expense	6,381			4,689
Less income tax benefits	(514		)	(341		)
Share-based compensation expense, net of income tax benefits	$	5,867		$	4,348
Impact of share-based compensation on earnings per share from continuing operations:
Basic	$	0.23		$	0.16
Diluted	$	0.23		$	0.16

	Six Months Ended August 31,
(in thousands, except per share data)	2019			2018
Stock options	$	151		$	527
Directors stock compensation	281			246
Performance based and other stock awards	13,228			9,918
Employee stock purchase plan	325			322
Share-based compensation expense	13,985			11,013
Less income tax benefits	(1,091		)	(611		)
Share-based compensation expense, net of income tax benefits	$	12,894		$	10,402
Impact of share-based compensation on earnings per share from continuing operations:
Basic	$	0.51		$	0.39
Diluted	$	0.51		$	0.39

XML

Long-Term Debt

6 Months Ended

Aug. 31, 2019

Debt Disclosure [Abstract]

Long-Term Debt

Long-Term Debt

We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provided for an unsecured total revolving commitment of $1.0 billion as of August 31, 2019. The commitment under the Credit Agreement terminates on December 7, 2021. Borrowings accrue interest under one of two alternative methods (based upon a base rate of LIBOR) as described in the Credit Agreement. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time.  We also incur loan commitment fees and letter of credit fees under the Credit Agreement.  Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis.  As of August 31, 2019, the outstanding revolving loan principal balance was $283.0 million (excluding prepaid financing fees) and the face amount of outstanding letters of credit was $9.0 million. For the three and six month periods ended August 31, 2019, borrowings under the Credit Agreement incurred interest charges at rates ranging from 3.1% to 5.5%. For the three and six month periods ended August 31, 2018, borrowings under the Credit Agreement incurred interest charges at rates ranging from 2.9% to 5.0% and 2.8% to 5.0%, respectively. As of August 31, 2019, the amount available for borrowings under the Credit Agreement was $708.0 million. Covenants in our debt agreements limit the amount of total indebtedness we can incur.  As of August 31, 2019, these covenants effectively limited our ability to incur more than $609.0 million of additional debt from all sources, including our Credit Agreement, or $708.0 million in the event a qualified acquisition is consummated.  The following table summarizes our long-term debt as of the end of the periods shown:

(in thousands)	Original Date Borrowed	Interest Rates	Matures	August 31, 2019			February 28, 2019
Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1)	03/13	Floating	03/23	$	20,443		$	22,335
Credit Agreement (2)	01/15	Floating	12/21	280,750			298,449
Total long-term debt				301,193			320,784
Less current maturities of long-term debt				(1,884		)	(1,884		)
Long-term debt, excluding current maturities				$	299,309		$	318,900

(1) The MBFC Loan is unsecured with an original balance of $37.6 million and incurs floating interest based on applicable LIBOR plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder’s call on or after March 1, 2018.  The loan can be prepaid without penalty.  The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and $14.8 million on March 1, 2023.  Any remaining outstanding principal and interest is due upon maturity on March 1, 2023.

(2) Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement.  Notes 13 and 14 to these condensed consolidated financial statements provide additional information regarding the interest rate swaps.

At August 31, 2019 and February 28, 2019, our long-term debt has floating interest rates, and its book value approximates its fair value. 

All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries.  Our debt agreements require the maintenance of certain financial covenants, including a maximum leverage ratio and a minimum interest coverage ratio (as each of these terms is defined in the agreements).  Our debt agreements also contain other customary covenants.  We were in compliance with the terms of these agreements as of August 31, 2019.

XML

Segment Information (Tables)

6 Months Ended

Aug. 31, 2019

Segment Reporting [Abstract]

Schedule of segment information

The following tables present segment information included in continuing operations for the periods shown:

	Three Months Ended August 31, 2019
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	167,864	$	158,790	$	87,341	$	413,995
Restructuring charges	2		—		428		430
Operating income	35,698		12,408		6,414		54,520
Capital and intangible asset expenditures	3,215		1,518		410		5,143
Depreciation and amortization	1,416		4,269		2,664		8,349

	Three Months Ended August 31, 2018
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	137,498	$	175,783	$	80,267	$	393,548
Restructuring charges	—		—		859		859
Operating income	28,329		13,631		8,700		50,660
Capital and intangible asset expenditures	5,642		2,466		771		8,879
Depreciation and amortization	1,522		4,229		1,562		7,313

	Six Months Ended August 31, 2019
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	312,806	$	313,733	$	163,791	$	790,330
Restructuring charges	90		—		959		1,049
Operating income	66,898		27,464		7,365		101,727
Capital and intangible asset expenditures	6,082		2,198		581		8,861
Depreciation and amortization	3,029		8,582		4,505		16,116

	Six Months Ended August 31, 2018
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	254,801	$	339,214	$	154,212	$	748,227
Restructuring charges	760		358		1,466		2,584
Operating income	50,512		33,288		10,187		93,987
Capital and intangible asset expenditures	7,296		4,655		1,110		13,061
Depreciation and amortization	3,006		8,377		3,912		15,295

XML

Commitment and Contingencies (Tables)

6 Months Ended

Aug. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Other Commitments

The lease commitments as of February 28, 2019 were as follows:

	Fiscal Years Ended the Last Day of February:
			2020		2021		2022		2023		2024		After
(in thousands)	Total		1 year		2 years		3 years		4 years		5 years		5 years
Operating leases	$	69,482	$	5,171	$	6,678	$	6,411	$	5,743	$	5,078	$	40,401

XML

Share-Based Compensation Plans Share Based Compensation Expense in SG&A (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense, net of income tax benefits	$ 5,867	$ 4,348	$ 12,894	$ 10,402
Share Based Compensation Effect on Earnings Per Share [Abstract]
Basic (in dollars per share)	$ 0.23	$ 0.16	$ 0.51	$ 0.39
Diluted (in dollars per share)	$ 0.23	$ 0.16	$ 0.51	$ 0.39
SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 6,381	$ 4,689	$ 13,985	$ 11,013
Less income tax benefits	(514)	(341)	(1,091)	(611)
Stock options | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	35	219	151	527
Performance based and other stock awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	6,205	4,347	13,228	9,918
Employee stock purchase plan | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	0	0	325	322
Directors stock compensation | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 141	$ 123	$ 281	$ 246

XML

Commitments and Contingencies - Lease Commitments (Details) - Lease Agreements $ in Thousands	Aug. 31, 2019 USD ($)
Other Commitments [Line Items]
Total	$ 69,482
2020	5,171
2021	6,678
2022	6,411
2023	5,743
2024	5,078
After 5 years	$ 40,401

XML

Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2019	Feb. 28, 2019
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 261,223	$ 254,082
Less accumulated depreciation	(130,059)	(123,744)
Property and equipment, net	131,164	130,338
Land
PROPERTY AND EQUIPMENT
Property and equipment, gross	12,644	12,644
Building and improvements
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 113,619	113,820
Building and improvements | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Building and improvements | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	40 years
Computer, software, furniture and other equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 86,699	84,711
Computer, software, furniture and other equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Computer, software, furniture and other equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	15 years
Tools, molds and other production equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 37,000	36,378
Tools, molds and other production equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Tools, molds and other production equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	7 years
Construction in progress
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 11,261	$ 6,529

XML

Leases - Additional Lease Information (Details) $ in Thousands	6 Months Ended
	Aug. 31, 2019 USD ($)
Leases [Abstract]
Weighted average remaining lease term (years)	11 years 1 month 6 days
Weighted average discount rate	6.09%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 2,112

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Feb. 28, 2018		26,576,000
Beginning balance at Feb. 28, 2018	$ 1,014,459	$ 2,658	$ 230,676	$ 631	$ 780,494
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	82,190				82,190
Loss from discontinued operations	(381)				(381)
Other comprehensive income (loss), net of tax	4,016			4,016
Exercise of stock options (in shares)		111,000
Exercise of stock options	5,515	$ 11	5,504
Net issuance and settlement of restricted stock (in shares)		140,000
Net issuance and settlement of restricted stock	0	$ 14	(14)
Issuance of common stock related to stock purchase plan (in shares)		17,000
Issuance of common stock related to stock purchase plan	$ 1,335	$ 2	1,333
Common stock repurchased and retired (in shares)	(57,072,000)	(464,000)
Common stock repurchased and retired	$ (42,240)	$ (46)	(6,877)		(35,317)
Share-based compensation	11,013		11,013
Ending balance (in shares) at Aug. 31, 2018		26,380,000
Ending balance at Aug. 31, 2018	1,075,740	$ 2,635	241,633	4,647	826,825
Beginning balance (in shares) at May. 31, 2018		26,317,000
Beginning balance at May. 31, 2018	1,023,697	$ 2,629	233,783	4,068	783,217
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	44,017				44,017
Loss from discontinued operations	0
Other comprehensive income (loss), net of tax	579			579
Exercise of stock options (in shares)		67,000
Exercise of stock options	3,459	$ 7	3,452
Net issuance and settlement of restricted stock (in shares)		3,000
Net issuance and settlement of restricted stock	0
Issuance of common stock related to stock purchase plan	$ 0
Common stock repurchased and retired (in shares)	(7,477,000)	(7,000)
Common stock repurchased and retired	$ (692)		(292)		(400)
Share-based compensation	4,689		4,689
Ending balance (in shares) at Aug. 31, 2018		26,380,000
Ending balance at Aug. 31, 2018	1,075,740	$ 2,635	241,633	4,647	826,825
Beginning balance (in shares) at Feb. 28, 2019		24,946,000
Beginning balance at Feb. 28, 2019	996,637	$ 2,495	246,585	1,191	746,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	86,789				86,789
Other comprehensive income (loss), net of tax	$ (5,946)			(5,946)
Exercise of stock options (in shares)	61,765	62,000
Exercise of stock options	$ 3,633	$ 6	3,627
Net issuance and settlement of restricted stock (in shares)		178,000
Net issuance and settlement of restricted stock	0	$ 18	(18)
Issuance of common stock related to stock purchase plan (in shares)		15,000
Issuance of common stock related to stock purchase plan	$ 1,408	$ 1	1,407
Common stock repurchased and retired (in shares)	(70,558,000)	(71,000)
Common stock repurchased and retired	$ (9,131)	$ (7)	(8,591)		(533)
Share-based compensation	13,985		13,985
Ending balance (in shares) at Aug. 31, 2019		25,130,000
Ending balance at Aug. 31, 2019	1,087,375	$ 2,513	256,995	(4,755)	832,622
Beginning balance (in shares) at May. 31, 2019		25,101,000
Beginning balance at May. 31, 2019	1,036,179	$ 2,510	249,079	(2,011)	786,601
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	46,095				46,095
Other comprehensive income (loss), net of tax	$ (2,744)			(2,744)
Exercise of stock options (in shares)	26,368	27,000
Exercise of stock options	$ 1,807	$ 2	1,805
Net issuance and settlement of restricted stock (in shares)		5,000
Net issuance and settlement of restricted stock	0	$ 1	(1)
Issuance of common stock related to stock purchase plan (in shares)		0
Issuance of common stock related to stock purchase plan	$ 0	$ 0	0
Common stock repurchased and retired (in shares)	(2,354,000)	(3,000)
Common stock repurchased and retired	$ (343)		(269)		(74)
Share-based compensation	6,381		6,381
Ending balance (in shares) at Aug. 31, 2019		25,130,000
Ending balance at Aug. 31, 2019	$ 1,087,375	$ 2,513	$ 256,995	$ (4,755)	$ 832,622

XML

Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
Assets, current:
Cash and cash equivalents	$ 17,031	$ 11,871
Receivables - principally trade, less allowances of $1,350 and $2,032	310,377	280,280
Inventory	370,915	302,339
Prepaid expenses and other current assets	13,048	10,369
Total assets, current	711,371	604,859
Property and equipment, net of accumulated depreciation of $130,059 and $123,744	131,164	130,338
Goodwill	602,320	602,320
Other intangible assets, net of accumulated amortization of $189,771 and $181,463	283,186	291,526
Operating lease assets	34,429
Deferred tax assets, net	12,398	7,991
Other assets, net of accumulated amortization of $2,161 and $2,115	1,085	12,501
Total assets	1,775,953	1,649,535
Liabilities, current:
Accounts payable, principally trade	166,684	143,560
Accrued expenses and other current liabilities	149,271	165,160
Income taxes payable	18	1,427
Long-term debt, current maturities	1,884	1,884
Total liabilities, current	317,857	312,031
Long-term debt, excluding current maturities	299,309	318,900
Lease liabilities, non-current	42,470
Deferred tax liabilities, net	8,323	5,748
Other liabilities, non-current	20,619	16,219
Total liabilities	688,578	652,898
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	0	0
Common stock, $0.10 par. Authorized 50,000,000 shares; 25,130,204 and 24,946,046 shares issued and outstanding	2,513	2,495
Additional paid in capital	256,995	246,585
Accumulated other comprehensive income (loss)	(4,755)	1,191
Retained earnings	832,622	746,366
Total stockholders' equity	1,087,375	996,637
Total liabilities and stockholders' equity	$ 1,775,953	$ 1,649,535

XML

Financial Instruments and Risk Management (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
SG&A
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	$ 0.8	$ 0.5	$ 1.6	$ (1.2)
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk and Currency Exchange Uncertainties
Concentration risk percentage	14.00%	11.00%	13.00%	13.00%

XML

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Segment information
Sales revenue, net	$ 413,995	$ 393,548	$ 790,330	$ 748,227
Restructuring charges	430	859	1,049	2,584
Operating income	54,520	50,660	101,727	93,987
Capital and intangible asset expenditures	5,143	8,879	8,861	13,061
Depreciation and amortization	8,349	7,313	16,116	15,295
Housewares
Segment information
Sales revenue, net	167,864	137,498	312,806	254,801
Restructuring charges	2	0	90	760
Operating income	35,698	28,329	66,898	50,512
Capital and intangible asset expenditures	3,215	5,642	6,082	7,296
Depreciation and amortization	1,416	1,522	3,029	3,006
Health and Home
Segment information
Sales revenue, net	158,790	175,783	313,733	339,214
Restructuring charges	0	0	0	358
Operating income	12,408	13,631	27,464	33,288
Capital and intangible asset expenditures	1,518	2,466	2,198	4,655
Depreciation and amortization	4,269	4,229	8,582	8,377
Beauty
Segment information
Sales revenue, net	87,341	80,267	163,791	154,212
Restructuring charges	428	859	959	1,466
Operating income	6,414	8,700	7,365	10,187
Capital and intangible asset expenditures	410	771	581	1,110
Depreciation and amortization	$ 2,664	$ 1,562	$ 4,505	$ 3,912

XML

Income Taxes

6 Months Ended

Aug. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate.

For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items.

For the three months ended August 31, 2019, income tax expense as a percentage of income before income tax was 10.3% compared to 8.3% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates.

For the six months ended August 31, 2019, income tax expense as a percentage of income before income tax was 9.0%, which included $0.8 million of tax benefits from share-based compensation settlements, $1.7 million of expense from the remeasurement of deferred taxes due to tax rate changes, and a $2.8 million benefit from the resolution of an uncertain tax position. Income tax expense as a percentage of income before income tax was 7.3% for the same period last year, which included $0.5 million tax benefits from share-based compensation settlements and a $0.8 million benefit from the lapse of the statute of limitations related to an uncertain tax position. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates.

During fiscal 2017, we received an assessment from a state tax authority which adjusted taxable income applicable to the particular state resulting from interpretations of certain state income tax provisions applicable to our legal structure.  We believe we have accurately reported our taxable income and are vigorously protesting the assessment through administrative processes with the state.  We believe it is unlikely that the outcome of these matters will have a material adverse effect on our consolidated financial position, results of operations, or liquidity.

Our Macau subsidiary generates income from the sale of the goods that it has sourced and procured. This subsidiary is responsible for the sourcing and procurement of a large portion of the products that we sell. We currently have an indefinite tax holiday in Macau conditioned on the subsidiary meeting certain employment and investment thresholds. The Macau Offshore Law and its supplementary regulations that grant tax incentives to approved offshore institutions will be abolished on January 1, 2021. Existing approved offshore institutions such as ours can continue to operate under the offshore regime until the end of the calendar year 2020. Beginning in calendar year 2021, we believe our Macau subsidiary will become subject to a statutory corporate income tax of approximately 12%. The ultimate impact of this change, if any, on our overall effective tax rate will depend on a variety of factors including our mix of income by jurisdiction, transfer pricing considerations and the specific tax regulations applicable to us when we are no longer under the Macau Offshore regime. It is not practicable for us to determine the potential impact on our financial statements until the tax changes in Macau are fully established and our transfer pricing analysis is complete. Because our Macau subsidiary is not directly or indirectly owned by a U.S. parent, there is no U.S. tax liability associated with the income generated in Macau.

XML

Leases (Tables)

6 Months Ended

Aug. 31, 2019

Leases [Abstract]

Additional Lease Information

A summary of supplemental lease information is as follows:

	August 31, 2019
Weighted average remaining lease term (years)	11.1
Weighted average discount rate	6.09		%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,112

Schedule of Operating Lease Maturities

A summary of our estimated lease payments, imputed interest and liabilities are as follows:

(in thousands)
Fiscal 2020 (balance for remainder of fiscal year)	$	2,470
Fiscal 2021	6,082
Fiscal 2022	5,959
Fiscal 2023	5,601
Fiscal 2024	5,102
Thereafter	40,132
Total future lease payments	65,346
Less: imputed interest	(19,721		)
Present value of lease liability	$	45,625

Schedule of Lease Liabilities

	August 31, 2019
Lease liabilities, current (1)	$	3,155
Lease liabilities, non-current	42,470
Total lease liability	$	45,625

^{(1) Included as part of "Accrued expenses and other current liabilities" on the condensed consolidated balance sheet.}  

XML

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018
Cash provided by operating activities:
Net income	$ 86,789	$ 81,809
Less: Loss from discontinued operations	0	(381)
Income from continuing operations	86,789	82,190
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation and amortization	16,116	15,295
Amortization of financing costs	509	507
Non-cash operating lease asset amortization	1,022
Provision for doubtful receivables	313	597
Non-cash share-based compensation	13,985	11,013
(Gain) loss on the sale or disposal of property and equipment	(13)	49
Deferred income taxes and tax credits	4	5,650
Changes in operating capital, net of effects of acquisition of businesses:
Receivables	(30,410)	(38,647)
Inventories	(68,576)	(33,317)
Prepaid expenses and other current assets	(2,333)	(5,169)
Other assets and liabilities, net	22,284	(906)
Accounts payable	23,124	21,867
Accrued expenses and other current liabilities	(20,418)	(21,529)
Accrued income taxes	(4,185)	(289)
Net cash provided by operating activities - continuing operations	38,211	37,311
Net cash used by operating activities - discontinued operations	0	(381)
Net cash provided by operating activities	38,211	36,930
Cash used by investing activities:
Capital and intangible asset expenditures	(8,861)	(13,061)
Proceeds from the sale of property and equipment	0	0
Net cash used by investing activities - continuing operations	(8,861)	(13,061)
Net cash used by investing activities - discontinued operations	0	0
Net cash used by investing activities	(8,861)	(13,061)
Cash used by financing activities:
Proceeds from line of credit	283,400	292,300
Repayment of line of credit	(301,600)	(279,700)
Repayment of long-term debt	(1,900)	(1,900)
Proceeds from share issuances under share-based compensation plans	5,041	6,848
Payments for repurchases of common stock	(9,131)	(42,240)
Net cash used by financing activities - continuing operations	(24,190)	(24,692)
Net cash used by financing activities - discontinued operations	0	0
Net cash used by financing activities	(24,190)	(24,692)
Net decrease in cash and cash equivalents	5,160	(823)
Cash and cash equivalents, beginning balance	11,871	20,738
Cash and cash equivalents, ending balance	17,031	19,915
Less: Cash and cash equivalents of discontinued operations, ending balance	0	0
Cash and cash equivalents of continuing operations, ending balance	17,031	$ 19,915
Supplemental non-cash items not included above resulting from the adoption of ASC 842
Initial recognition of lease liabilities	$ 45,625

XML

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
Statement of Financial Position [Abstract]
Receivables - principally trade, allowances (in dollars)	$ 1,350	$ 2,032
Property and equipment, accumulated depreciation (in dollars)	130,059	123,744
Other intangible assets, accumulated amortization (in dollars)	189,771	181,463
Other assets, accumulated amortization (in dollars)	$ 2,161	$ 2,115
Cumulative preferred stock, non-voting, par (in dollars per share)	$ 1	$ 1
Cumulative preferred stock, non-voting, authorized shares (in shares)	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares (in shares)	0	0
Common stock, par (in dollars per share)	$ 0.10	$ 0.10
Common stock, authorized shares (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	25,130,204	24,946,046
Common stock, shares outstanding (in shares)	25,130,204	24,946,046

XML

Supplemental Balance Sheet Information - Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued compensation, benefits and payroll taxes	$ 29,159	$ 36,782
Accrued sales discounts and allowances	28,924	28,655
Accrued sales returns	21,359	23,316
Accrued advertising	28,060	26,549
Other	41,769	49,858
Total accrued expenses and other current liabilities	$ 149,271	$ 165,160

XML

Leases - Schedule of Operating Lease Maturities (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Mar. 01, 2019
Leases [Abstract]
Fiscal 2020 (balance for remainder of fiscal year)	$ 2,470
Fiscal 2021	6,082
Fiscal 2022	5,959
Fiscal 2023	5,601
Fiscal 2024	5,102
Thereafter	40,132
Total future lease payments	65,346
Less: imputed interest	(19,721)
Present value of lease liability	$ 45,625	$ 47,223

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,036,179	$ 1,023,697	$ 996,637	$ 1,014,459
Total other comprehensive income (loss), net of tax	(2,744)	579	(5,946)	4,016
Ending balance	1,087,375	1,075,740	1,087,375	1,075,740
Interest Rate Swaps
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			132	1,705
Other comprehensive income (loss) before reclassification			(9,326)	76
Amounts reclassified out of accumulated other comprehensive income			0	0
Tax effects			2,165	129
Total other comprehensive income (loss), net of tax			(7,161)	205
Ending balance	(7,029)	1,910	(7,029)	1,910
Foreign Currency Contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			1,059	(1,074)
Other comprehensive income (loss) before reclassification			(668)	4,525
Amounts reclassified out of accumulated other comprehensive income			2,210	(77)
Tax effects			(327)	(637)
Total other comprehensive income (loss), net of tax			1,215	3,811
Ending balance	2,274	2,737	2,274	2,737
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(2,011)	4,068	1,191	631
Other comprehensive income (loss) before reclassification			(9,994)	4,601
Amounts reclassified out of accumulated other comprehensive income			2,210	(77)
Tax effects			1,838	(508)
Total other comprehensive income (loss), net of tax	(2,744)	579	(5,946)	4,016
Ending balance	$ (4,755)	$ 4,647	$ (4,755)	$ 4,647

XML

Fair Value (Details) - Recurring - Fair Values - Significant other observable market inputs (Level 2) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
Assets:
Total assets	$ 4,714	$ 3,119
Liabilities:
Total liabilities	310,345	321,686
Interest rate swap
Assets:
Derivative assets	0	512
Liabilities:
Derivative assets	9,152	339
Foreign currency contracts
Assets:
Derivative assets	3,482	1,692
Liabilities:
Derivative assets	0	563
Floating rate debt
Liabilities:
Floating rate debt	301,193	320,784
Money market accounts
Assets:
Money market accounts	$ 1,232	$ 915

XML

Financial Instruments and Risk Management - Derivative tax effect (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	$ (4,608)		$ (9,994)
Gain (Loss) Recognized in OCI (effective portion)		$ 86		$ 4,601
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	(992)		(2,210)
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		(610)		77
Gain (Loss) Recognized As Income	421		1,113
Gain (Loss) Recognized As Income		379		951
Foreign currency contracts | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Recognized As Income	0		0
Gain (Loss) Recognized As Income		0		0
Foreign currency contracts | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	(482)		(668)
Gain (Loss) Recognized in OCI (effective portion)		(51)		4,525
Net loss currently reported in accumulated other comprehensive income, to be reclassified into income			$ 100
Net loss currently reported in accumulated other comprehensive income, to be reclassified into income, period of time to transfer			12 months
Foreign currency contracts | Cash flow hedges | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	(992)		$ (2,210)
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		(610)		77
Interest rate swaps | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Recognized As Income	77		231
Gain (Loss) Recognized As Income		136		211
Interest rate swaps | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	(4,126)		(9,326)
Gain (Loss) Recognized in OCI (effective portion)		137		76
Interest rate swaps | Cash flow hedges | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		0		0
Cross currency debt swaps
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	0		0
Gain (Loss) Recognized in OCI (effective portion)		0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		0		0
Cross currency debt swaps | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		0		0
Gain (Loss) Recognized As Income	344		808
Gain (Loss) Recognized As Income		243		666
Cross currency debt swaps | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Recognized As Income	$ 0		$ 74
Gain (Loss) Recognized As Income		$ 0		$ 74

XML

Segment Information

6 Months Ended

Aug. 31, 2019

Segment Reporting [Abstract]

Segment Information

Segment Information

The following tables present segment information included in continuing operations for the periods shown:

	Three Months Ended August 31, 2019
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	167,864	$	158,790	$	87,341	$	413,995
Restructuring charges	2		—		428		430
Operating income	35,698		12,408		6,414		54,520
Capital and intangible asset expenditures	3,215		1,518		410		5,143
Depreciation and amortization	1,416		4,269		2,664		8,349

	Three Months Ended August 31, 2018
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	137,498	$	175,783	$	80,267	$	393,548
Restructuring charges	—		—		859		859
Operating income	28,329		13,631		8,700		50,660
Capital and intangible asset expenditures	5,642		2,466		771		8,879
Depreciation and amortization	1,522		4,229		1,562		7,313

	Six Months Ended August 31, 2019
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	312,806	$	313,733	$	163,791	$	790,330
Restructuring charges	90		—		959		1,049
Operating income	66,898		27,464		7,365		101,727
Capital and intangible asset expenditures	6,082		2,198		581		8,861
Depreciation and amortization	3,029		8,582		4,505		16,116

	Six Months Ended August 31, 2018
(in thousands)	Housewares		Health & Home		Beauty		Total
Sales revenue, net	$	254,801	$	339,214	$	154,212	$	748,227
Restructuring charges	760		358		1,466		2,584
Operating income	50,512		33,288		10,187		93,987
Capital and intangible asset expenditures	7,296		4,655		1,110		13,061
Depreciation and amortization	3,006		8,377		3,912		15,295

We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, restructuring charges, and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus shared service and corporate overhead expenses that are allocable to the segment.  We do not allocate non-operating income and expense, including interest or income taxes, to operating segments.

XML

New Accounting Pronouncements (Policies)

6 Months Ended

Aug. 31, 2019

Accounting Changes and Error Corrections [Abstract]

New Accounting Pronouncements, Policy

Adopted in Fiscal 2020

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The new guidance requires the recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and corresponding right-of-use assets on a balance sheet for most leases, along with requirements for enhanced disclosures to give financial statement users the ability to assess the amount, timing and uncertainty of cash flows arising from leasing arrangements. In July 2018, the FASB issued guidance which permits application of the new guidance at the beginning of the year of adoption, recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, in addition to the method of applying the new guidance retrospectively to each prior reporting period presented. We adopted the standard in the first quarter of fiscal 2020 using the transition method introduced by ASU 2018-11, which does not require revisions to comparative periods. We elected to implement the transition package of practical expedients permitted within the new standard, which included (i) not reassessing whether expired or existing contracts contain leases, (ii) not reassessing lease classification, and (iii) not revaluing initial direct costs for existing leases. Adoption of the new standard resulted in the recording of initial lease assets and lease liabilities of approximately $37.1 million and $47.2 million, respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to deferred rent and unamortized lease incentives recorded in accordance with the previous lease guidance. The new standard did not materially impact our condensed consolidated statements of income or cash flows (see Note 4).

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (Topic 815), which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. In April 2019, the FASB issued ASU 2019-04, which provides clarifications and minor improvements related to Topic 815. Adoption of this guidance in the first quarter of fiscal 2020 did not have a material impact on our consolidated financial statements.

XML

Commitments and Contingencies

6 Months Ended

Aug. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Matters – On May 31, 2018, we settled a patent infringement dispute related to two forehead thermometer models sold by our subsidiary, Kaz USA, Inc., in the United States and made a settlement payment of $15.0 million, which was accrued in prior periods along with related legal fees and other costs.      

We are involved in various other legal claims and proceedings in the normal course of operations.  We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

Lease Commitments – The implementation of the new lease guidance (ASC 842) using the effective date method requires the disclosure of our lease commitments from our latest annual report on Form 10-K for the interim periods during the first year of adoption (see Note 4). The lease commitments as of February 28, 2019 were as follows:

	Fiscal Years Ended the Last Day of February:
			2020		2021		2022		2023		2024		After
(in thousands)	Total		1 year		2 years		3 years		4 years		5 years		5 years
Operating leases	$	69,482	$	5,171	$	6,678	$	6,411	$	5,743	$	5,078	$	40,401

The minimum rental payments for operating leases presented above were determined in accordance with the previous lease guidance (ASC 840). Note 4 presents a summary of our estimated lease payments, imputed interest and liabilities as of August 31, 2019, in accordance with the new lease guidance (ASC 842).

XML

Revenue Recognition

6 Months Ended

Aug. 31, 2019

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Revenue Recognition

We adopted the provisions of ASU 2014-9 in the first quarter of fiscal 2019, and we elected to adopt the standard using the retrospective method. The core principle of the guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. 

Our revenue is primarily generated from the sale of non-customized consumer products to customers. Revenue is recognized when control of, and title to, the product sold transfers to the customer. Therefore, the timing and amount of revenue recognized was not materially impacted by the new guidance. We have thus concluded that the adoption of the guidance did not have a material impact on our consolidated financial statements. The provisions of the new guidance did however impact the classification of certain consideration paid to our customers. We therefore reclassified an immaterial amount of such payments from SG&A to a reduction of net sales revenue for all periods presented. Also,

in accordance with the guidance, we reclassified an immaterial amount of estimated sales returns from a reduction of receivables to accrued expenses and other current liabilities for all periods presented.  We elected to adopt the guidance using the full retrospective method. 

We measure revenue as the amount of consideration for which we expect to be entitled, in exchange for transferring goods.  Certain customers may receive cash incentives such as customer discounts (including volume or trade discounts), advertising discounts and other customer-related programs which are accounted for as variable consideration.  In some cases, we apply judgment, such as contractual rates and historical payment trends, when estimating variable consideration.  In accordance with the guidance, most variable consideration is classified as a reduction to net sales.

Sales taxes and other similar taxes are excluded from revenue.  We elected to account for shipping and handling activities as a fulfillment cost as permitted by the guidance.  We do not have unsatisfied performance obligations since our performance obligations are satisfied at a single point in time.

XML

Goodwill and Intangible Assets

6 Months Ended

Aug. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

We perform annual impairment tests each fiscal year during the fourth quarter and interim impairment tests, if and when necessary. For the three and six month periods ended August 31, 2019 and 2018, we did not record any impairment charges.

The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented:

	August 31, 2019										February 28, 2019
(in thousands)	Gross Carrying Amount		Cumulative Goodwill Impairments			Accumulated Amortization			Net Book Value		Gross Carrying Amount		Cumulative Goodwill Impairments			Accumulated Amortization			Net Book Value
Housewares:
Goodwill	$	282,056	$	—		$	—		$	282,056	$	282,056	$	—		$	—		$	282,056
Trademarks - indefinite	134,200		—			—			134,200		134,200		—			—			134,200
Other intangibles - finite	41,328		—			(20,066		)	21,262		41,417		—			(19,398		)	22,019
Subtotal	457,584		—			(20,066		)	437,518		457,673		—			(19,398		)	438,275
Health & Home:
Goodwill	284,913		—			—			284,913		284,913		—			—			284,913
Trademarks - indefinite	54,000		—			—			54,000		54,000		—			—			54,000
Licenses - finite	17,050		—			(15,577		)	1,473		17,050		—			(15,402		)	1,648
Licenses - indefinite	7,400		—			—			7,400		7,400		—			—			7,400
Other intangibles - finite	118,024		—			(93,373		)	24,651		117,967		—			(87,953		)	30,014
Subtotal	481,387		—			(108,950		)	372,437		481,330		—			(103,355		)	377,975
Beauty:
Goodwill	81,841		(46,490		)	—			35,351		81,841		(46,490		)	—			35,351
Trademarks - indefinite	—		—			—			—		30,407		—			—			30,407
Trademarks - finite	30,557		—			(1,956		)	28,601		150		—			(102		)	48
Licenses - indefinite	10,300		—			—			10,300		10,300		—			—			10,300
Licenses - finite	13,696		—			(12,641		)	1,055		13,696		—			(12,482		)	1,214
Other intangibles - finite	46,402		—			(46,158		)	244		46,402		—			(46,126		)	276
Subtotal	182,796		(46,490		)	(60,755		)	75,551		182,796		(46,490		)	(58,710		)	77,596
Total	$	1,121,767	$	(46,490	)	$	(189,771	)	$	885,506	$	1,121,799	$	(46,490	)	$	(181,463	)	$	893,846

After discontinuing the formal sale process and revising the strategic initiatives for our Personal Care business during the first quarter of fiscal year 2020, we changed trademarks related to the business with a net book value of $30.4 million from indefinite lived to finite lived assets. The amortization of these trademarks is now included in amortization expense for the six months ended August 31, 2019, and these assets are expected to be fully amortized by the end of fiscal year 2027.

The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2020 through 2025:

Aggregate Amortization Expense
For the three months ended (in thousands)
August 31, 2019	$	4,463
August 31, 2018	3,402

Aggregate Amortization Expense
For the six months ended (in thousands)
August 31, 2019	$	8,339
August 31, 2018	7,522

Estimated Amortization Expense (in thousands)
Fiscal 2020	$	17,691
Fiscal 2021	16,135
Fiscal 2022	9,037
Fiscal 2023	8,847
Fiscal 2024	8,441
Fiscal 2025	6,977

XML

Earnings per Share (Tables)

6 Months Ended

Aug. 31, 2019

Earnings Per Share [Abstract]

Schedule of components of basic and diluted shares

The following table presents our weighted average basic and diluted shares for the periods shown:

	Three Months Ended August 31,		Six Months Ended August 31,
(in thousands)	2019	2018	2019	2018
Weighted average shares outstanding, basic	25,116	26,359	25,068	26,467
Incremental shares from share-based compensation arrangements	129	198	177	145
Weighted average shares outstanding, diluted	25,245	26,557	25,245	26,612
Antidilutive securities	166	194	259	352

XML

Long-Term Debt (Tables)

6 Months Ended

Aug. 31, 2019

Debt Disclosure [Abstract]

Summary of long-term debt

The following table summarizes our long-term debt as of the end of the periods shown:

(in thousands)	Original Date Borrowed	Interest Rates	Matures	August 31, 2019			February 28, 2019
Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1)	03/13	Floating	03/23	$	20,443		$	22,335
Credit Agreement (2)	01/15	Floating	12/21	280,750			298,449
Total long-term debt				301,193			320,784
Less current maturities of long-term debt				(1,884		)	(1,884		)
Long-term debt, excluding current maturities				$	299,309		$	318,900

(1) The MBFC Loan is unsecured with an original balance of $37.6 million and incurs floating interest based on applicable LIBOR plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder’s call on or after March 1, 2018.  The loan can be prepaid without penalty.  The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and $14.8 million on March 1, 2023.  Any remaining outstanding principal and interest is due upon maturity on March 1, 2023.

(2) Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement.  Notes 13 and 14 to these condensed consolidated financial statements provide additional information regarding the interest rate swaps.

XML

Share-Based Compensation Plans (Details) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	Aug. 31, 2019 USD ($) $ / shares shares	Aug. 31, 2019 USD ($) $ / shares shares
Share-based compensation plans
Exercise of stock options (in shares)	26,368	61,765
Employee purchases of common stock (in shares)	0	14,790
Employee purchases of common stock, average price (in dollars per share) | $ / shares	$ 95.29	$ 95.29
Directors stock compensation
Share-based compensation plans
Number of awards granted (in shares)	1,048	2,304
Grant date fair value | $	$ 0.1	$ 0.2
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 134.21	$ 121.99
Restricted Stock Units (RSU)
Share-based compensation plans
Grant date fair value | $	$ 0.5	$ 7.6
Shares vested and settled (in shares)	3,489	66,329
Grant date fair value of shares settled in period (in dollars per share) | $ / shares	$ 146.26	$ 114.58
Shares vested (in shares)	3,489	66,329
Performance Restricted Stock Units (PSU)
Share-based compensation plans
Number of awards granted (in shares)	0	6,088
Grant date fair value | $		$ 0.7
Grant date fair value of shares granted in period (in dollars per share) | $ / shares		$ 110.85
Shares vested (in shares)	0	108,572
Performance Based Restricted Stock Awards (PSA)
Share-based compensation plans
Number of awards granted (in shares)	0	122,402
Grant date fair value | $		$ 13.6
Grant date fair value of shares settled in period (in dollars per share) | $ / shares		$ 110.85
Time-Vested | Restricted Stock Units (RSU)
Share-based compensation plans
Number of awards granted (in shares)	8	3,279
Grant date fair value | $		$ 0.4
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 150.86	$ 111.51
Time-Vested | Restricted Stock Awards (RSA)
Share-based compensation plans
Number of awards granted (in shares)	4,920	45,772
Grant date fair value | $	$ 0.7	$ 5.2
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 138.86	$ 113.98
Vested and settled performance shares | Restricted Stock Awards (RSA)
Share-based compensation plans
Grant date fair value | $	$ 0.1	$ 0.1
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 150.86	$ 150.86
Shares vested and settled (in shares)	928	928
Vested and settled performance shares | Performance Restricted Stock Units (PSU)
Share-based compensation plans
Grant date fair value | $		$ 14.7
Grant date fair value of shares granted in period (in dollars per share) | $ / shares		$ 135.85
Shares vested and settled (in shares)	0	108,572

XML

Commitments and Contingencies (Details) $ in Millions	May 31, 2018 USD ($)
Thermometer Patent Litigation | Settled Litigation
Commitments and contingencies
Settlement payment	$ 15.0